序号,label,cleaned_text
1,Lung_Cancer,lack biomarkers identifying aggressive primary tumor subsets give rise metastases impact early detection treatment many solid tumors known accumulate hyaluronan ha glycosaminoglycan also produced tumor cells report quantitative approach uncovering breast heterogeneity using fluorescent ha detect differential binding patterns cd rhamm hmmr receptors approach permits identification tumor cell subsets bind high levels ha may applicable ligands receptors disease models despite representing invasive metastatic subset parental tumors unexpectedly high ha binding subset slow growing thus likely source dormancy relapse tumor heterogeneity confounds diagnosis outcome therapy necessitating analysis tumor cell subsets within tumor mass elevated expression hyaluronan ha
2,Lung_Cancer,inhibitors causing immediate nearly complete intracellular extracellular thiamine deprivation previous studies shown thiaminase vitro vivo cytotoxicity activity supporting concept tdes could represent new targets novel therapies also previously reported rapamycin antagonistic effect thiaminase mediated growth inhibition leukemia cells surprising finding since rapamycin generally acts sensitizing agent combination cytotoxic drugs present metabolic metabolomic observations regarding anticancer activities metabolic effects thiaminase leukemia breast cells chose focus breast leukemia models models observed promising activity thiaminase xenografts studies help define thiaminase metabolic effects may responsible cytotoxic activity studies also elucidate role mtor inhibitor thiaminase mediated alterations cellular metabolism demonstrate role
3,Lung_Cancer,days untreated control days p log rank test b kaplan meyer plot time pre defined tumor volume endpoint subcutaneous rs leukemia subcutaneous xenografts treated thiaminase units sc biw buffer control median time endpoint days control group reached days observation treated group p log rank test c primary aml specimens thawed plated triplicate two concentrations thiaminase units ml units ml assessed viability hours relative untreated cells specimen asterisk used vivo study shown primary cells injected iv day three thiaminase treatments units kg sc administered days animals sacrificed day bone marrow examined flow cytometry human cells percent human
4,Lung_Cancer,cells treated thiaminase consistent inhibition bckdh complex pyruvate dehydrogenase complex transketolase inhibition however inhibition enzyme shown result different metabolic consequences case bckdh inhibition rs cells caused demonstrable increase bckdh substrates whereas mcf cells inhibition led decrease products enzymatic reaction difference may lead different consequences cell growth substrates bckdh known toxic metabolites result toxicity metabolic syndrome maple syrup urine disease previously shown rs cells well lymphoid leukemia cell lines biphasic dose response thiaminase initial growth inhibition related extracellular thiamine depletion cytotoxic response higher concentrations related intracellular thiamine depletion gabapentin appears protective growth inhibitory effects thiaminase rs cells
5,Lung_Cancer,creative commons public domain dedication waiver http creativecommons publicdomain zero applies data made available unless otherwise stated background complement receptor cr receptor c b c b complement peptides plays crucial role carcinogenesis however association genetic variants cr susceptibility remains unexplored methods case control study included non small cell nsclc patients free controls based chinese population data hapmap database used haploview program select candidate tag snps odds ratios ors confidence intervals cis computed logistic regression evaluate association tag snp nsclc results multivariate regression analysis indicated rs cc genotype associated increased risk developing nsclc ci p compared gg
6,Lung_Cancer,statistical analysis used chi square test examine differences distributions demographic characteristics genotype frequencies cases controls nsclc risk associated cr tag snps estimated odds ratios confidence intervals ci computed logistic regression model adjusted age gender smoking status appropriate smokers considered current smokers smoked year date diagnosis nsclc patients date interview controls number pack years smoked determined indication cumulative cigarette dose level pack year cigarettes per day years smoked light heavy smokers categorized using th percentile pack year value controls cut points e pack years statistical tests sided p significant level statistical analyses done using spss version spss
7,Lung_Cancer,atment groups subgroupthe sum statistics along summary represented middle solid diamonds test heterogeneity trials within subgroup given summary statistics publication bias publication bias might exist nonsignificant findings remain unpublishedthus artificially inflating apparent magnitude effect funnel plots study shown funnel plots year survival rate following vats thoracotomy treatment metastatic showed asymmetry suggested publication bias g funnel plot outcome year survival rate discussion many tumors metastasize lungand colorectal breast tumors common primary tumors pulmonary resection shown beneficial patients resectable isolated pulmonary metastases traditional open thoracotomy vats two principally different surgical methods pulmonary metastasectomy selection approach depends theoretical knowledge
8,Lung_Cancer,nsclc healthy controls collected concentration klk measured enzyme linked immunosorbent assay elisa concentration klk nsclc significantly higher compared controls p serum klk levels decreased stage presence lymph node distant metastases regardless histology age sex cutoff point ng ml klk showed good diagnostic performance nsclc univariate analysis revealed nsclc patients serum high klk longer overall survival os progression free survival pfs low klk hr p hr p cox multivariate analysis indicated klk independent prognostic indicator pfs os hr p hr p kaplan meier survival curves confirmed patients high klk longer pfs os p p respectively measurement klk
9,Lung_Cancer,tissues fixed neutral formalin embedded paraffin cut thick slices took photographs record staining surface made axial slices covered center staining slices subjected hematoxylin eosin h e stain evaluate parenchymal change evaluated presence absence neutrophil infiltration vasculitis necrosis hemorrhage foam cell alveolus extent histopathologic finding estimated using visual grading scores focal diffuse localized parenchymal change total area surrounded normal defined focal extensive parenchymal change total area replaced normal defined diffuse experienced pathologist eight years experience reviewed slices overall severity parenchymal change defined total score adding visual grading scores histopathologic finding compared overall severity score mlm methylene blue
10,Lung_Cancer,oup n sacrificed hr percutaneous injection group b n sacrificed hr ct guided percutaneous injection mlm methylene blue fig examples evaluation staining surface photographs show extensive staining score b localized dispersion staining score c minimal dispersion staining score white lines bottom figure markings ruler distance two lines one centimeter fig examples assessment radio opacity fluoroscopic examinations fluoroscopic images show minimally increased opacity arrow score b low density increased opacity arrow score c compact nodular increased opacity arrow score fig ct corresponding photomicrograph specimen mlm group b discrete compact nodular opacity arrowheads b focal neutrophil infiltration necrosis
11,Lung_Cancer,ne diol epoxide bpde involved inducing dna adducts thus made predisposition adenocarcinoma besides method cooking throat eyes irritation interviewers also asked woman information cooking oil fumes exposure types cooking oils used frequency used stir frying deep frying prepare food ventilation conditions use fume extractor increasing epidemiological studies reported cooking method types cooking oils susceptibility among chinese females seow et al found women reported stir fried daily significantly increased risk ci risk enhanced stir fried meat daily ci elevated risk might attributed heterocyclic amines generated frying meats addition frequency stir frying seemed related susceptibility gao et al
12,Lung_Cancer,time fda approved diagnostic assays kras mutations later july kras mutation assay receive fda approval based results prospective randomized trial highlighting challenges retrospectively validating companion diagnostic assay pivotal drug trials completed anti egfr tki erlotinib initially approved patients advanced nsclc progressed first line chemotherapy number subsequent studies determined patients egfr mutant nsclc high likelihood responding tki leading trials first line setting egfr mutant four prospective randomized clinical trials studied asian populations demonstrated erlotinib gefitinib resulted improved progression free survival compared chemotherapy first line therapy nsclc patients egfr mutations clinical studies mixed ethnicity cohorts concluded similar results
13,Lung_Cancer,gfr pcr test required macrodissection tumor content performed one day using single section furthermore egfr pcr test commercially available kit based assay provides automated result rather manual process subject interpretation performed qualified clinical laboratory specimens tested study small biopsy specimens overall invalid rate sanger sequencing compared egfr pcr assay however invalid rate subset specimens derived resected specimens likely sufficient tissue availability thus assay extremely robust performed resected tumor specimens approximately success rate biopsy specimens often tumor sample available testing nsclc sanger sequencing widely used detect egfr mutations similar overall invalid rates egfr mutation detected ldt samples
14,Lung_Cancer,e commonest cause death england wales around cases diagnosed year deaths data national audit nlca demonstrate significant variation process outcome measures across england three fold difference survival active treatment rates persisted following case mix adjustment beckett et al furthermore reported outcomes uk worse comparable european countries walters et al improved little recent years khakwani et al estimated survival rates increased best europe around lives could saved year united kingdom abdel rahman et al variation health care unique addressing unwarranted variation challenging wise although external regulation may role areas approach difficult apply complex pathways involved diagnosis treatment
15,Lung_Cancer,design parallel group randomized controlled trial conducted compare mbsr tau patients received still treatment partners recruited assessments take place baseline post intervention three month follow primary outcome psychological distress e anxiety depressive symptoms secondary outcomes quality life patients caregiver appraisal partners relationship quality spirituality addition cost effectiveness ratio patients several process variables assessed discussion trial provide information clinical cost effectiveness mbsr compared tau patients partners trial registration clinicaltrials gov nct mindfulness based stress reduction patients partners psychological distress randomized controlled trial background estimated million deaths per year leading cause death worldwide even best available treatment five
16,Lung_Cancer,ssed entire study period calendar participants mbsr condition fill daily basis whether adhere mindfulness exercises either formal practice e g meditation exercise like bodyscan informal practice e g activity awareness exercise adherence mbsr shown mediate effects mbct depressive symptoms statistical analysis plan sample size determine required sample size first sample size calculated would needed simple test subsequently corrected clustering repeated measurements baseline two sided test total hads score e primary outcome measure examining psychological distress hads total anxiety symptoms hads depressive symptoms hads would require participants group power detect medium sized difference effect size alpha correct
17,Lung_Cancer,chen tao tchen partners righi elda elda righilibero bronson roderick roderick bronsonhms harvard edu chen huabiao hchen partners orsulic sandra sandra orsuliccshs brauns timothy tbraunspartners leblanc pierre pleblancmclean harvard edu scholler nathalie nathalie schollersri com dranoff glenn glenn dranoffdfci harvard edu gelfand jeffrey jgelfandpartners poznansky mark c mpoznanskypartners vaccine immunotherapy center division infectious diseases department medicine massachusetts general hospital th street charlestown boston usa department pathology harvard medical school boston usa ragon institute mgh mit harvard university boston usa women research institute cedars sinai medical center los angeles usa penn ovarian research center department obstetrics gynecology
18,Lung_Cancer,dcs ng ml lps equivalent amount endotoxin found g ml scfvmtbhsp h incubation scfvmtbhsp mtbhsp induced dc maturation indicated increase expression cd cd cd mhc class ii molecules comparison control cultures medium increased expression dc maturation markers comparable cells stimulated g ml lps contamination control showed addition ng ml lps replicate effects scfvmtbhsp mtbhsp allowing us discriminate scfvmtbhsp mtbhsp specific effects effects lps figure b scfvmtbhsp induces dc maturation promotes antigen presentation cross presentation cd c bmdcs isolated form fvb nj mice incubated h g ml scfvmtbhsp g ml mtbhsp g ml lps positive control ng
19,Lung_Cancer,mtbhsp flanks histopathology abdominal walls intestines mice fixed least h pbs buffered formalin tissues routinely embedded paraffin thick sections stained routinely h e staining tumor infiltrating cells mice perfused paraformaldehyde pfa pbs tumor nodules fixed pfa pbs additional hours washed infiltrated sucrose pbs c thick frozen sections stained rat anti mouse cd bd biosciences dilution rat anti mouse foxp ebioscience dilution followed polyclonal rabbit anti rat immunoglobulin hrp dako dilution signal developed diaminobenzidine dab dako images acquired zeiss axio microscope histopathological immunohistochemical samples reviewed quantitation cellular infiltrate performed blinded manner observer statistical analysis statistical differences three
20,Lung_Cancer,activation induced inhibitor mediated release negative feedback loops resulted significant tumor growth inhibition thus coinhibition pathways shown use reducing tumor growth variety xenograft models clinical trials combinations way adults bez orally available dual inhibitor pi k mtor evaluated phase ii trials aim developing effective therapeutic strategy treatment gefitinib resistant nsclcs initially evaluated antitumor activity azd alone combination bez panel three human nsclc cell lines selected according different mutation status egfr met kras pik ca genes hypothesized targeting mek pathway combination selective inhibitors pi k mtor signaling could overcome gefitinib resistant nsclc enhance antitumor efficacy methods reagents
21,Lung_Cancer,gatekeeper mutation monotherapy mutant selective egfr tki may sufficient inhibit growth tumors acquired resistance gefitinib findings suggest combination mek tki pik mtor tki may effective controlling resistant tumors many kras mutant cells shown sensitive mek inhibitors kras mutations detected dependent upon histology ethnicity suggesting subset would likely highly sensitive azd finding azd effective one distinct kras mutant human nci h models supports validates hypothesis although monotherapy azd resulted antitumor antiangiogenic effects models antitumor effects apparent nci h adenocarcinoma model increased antitumor efficacy observed model associated differences inhibitory effect p akt signaling pathway nci h nci h
22,Lung_Cancer,novel approach proton sabr warranted authors thank katy nelson maintaining sabr database references ged hillbrandm stockm dieckmannk potterr protons improve sbrt lesions dosimetric considerations radiotherapy oncology journal european society therapeutic radiology oncology hoppebs huhs flampouris nicholsrc oliverkr et al double scattered proton based stereotactic body radiotherapy stage dosimetric comparison photon based stereotactic body radiotherapy radiotherapy oncology journal european society therapeutic radiology oncology macdonaldok krusejj millerjm garcesyi brownpd et al proton beam radiotherapy versus three dimensional conformal stereotactic body radiotherapy primary peripheral early stage non small cell carcinoma comparative dosimetric analysis international journal radiation oncology biology physics
23,Lung_Cancer,n methylene blue vs cm p mlm showed superior staining ability methylene blue vs p excellent staining achieved subjects mlm methylene blue p acceptable excellent radio opacity mlm found subjects appropriate localization rate mlm use directly visible ability radio opacity mlm mlm provides superior pulmonary localization ability methylene blue ethiodized oil methylene blue tomography x ray computed radiology interventional seoul national university college medicine introduction preoperative localization necessary video assisted thoracoscopic surgery vats pulmonary nodules small distant visceral pleura detected failure localize nodules disturbs success thoracoscopic resection leads conversion thoracotomy two kinds localizing procedures marking thoracoscopically
24,Lung_Cancer,background complement receptor cr receptor c b c b complement peptides plays crucial role carcinogenesis however association genetic variants cr susceptibility remains unexplored methods case control study included non small cell nsclc patients free controls based chinese population data hapmap database used haploview program select candidate tag snps odds ratios ors confidence intervals cis computed logistic regression evaluate association tag snp nsclc results multivariate regression analysis indicated rs cc genotype associated increased risk developing nsclc ci p compared gg genotype stratified smoking status risk nsclc associated rs c allele carriers smokers ci non smokers ci interaction
25,Lung_Cancer,testing bal acc p value cross validation consistency rs rs rs rs rs rs generalized multifactor dimensionality reduction gmdr used evaluate gene gene interaction summary gene gene interaction models listed snp rs cr highest testing balanced accuracy among snps three way interaction model among rs rs rs showed high testing balance accuracy cross validation consistency testing balanced accuracy lower two way gene gene interaction nsclc model interaction significant p risk cr genotypes nsclc smoking status smoking status cr genotype gg ci p value cg cc ci p value non smoker reference smoker pack years pack years
26,Lung_Cancer,cc bruns ga weis jj klickstein lb wong ww fearon dt complement receptor locus genes encoding c b c b receptor c epstein barr virus receptor map q j immunol wilson jg wong ww murphy ee rd schur ph fearon dt deficiency c b c b receptor cr erythrocytes systemic lupus erythematosus analysis stability defect restriction fragment length polymorphism cr gene j immunol xiang l rundles jr hamilton dr wilson jg quantitative alleles cr coding sequence analysis comparison haplotypes two ethnic groups j immunol birmingham dj chen w liang g schmitt hc gavit k nagaraja hn
27,Lung_Cancer,associated erythrocyte sedimentation rate j hum genet j ajhg teeranaipong p ohashi j patarapotikul j kimura r nuchnoi p hananantachai h naka putaporntip c jongwutiwes tokunaga k functional single nucleotide polymorphism cr promoter region contributes protection cerebral malaria j infect dis chen gb xu xu hm li md zhu j lou xy practical theoretical considerations study design detecting gene gene interactions using mdr gmdr approaches plos one e lou xy chen gb yan l jz zhu j elston rc li md generalized combinatorial approach detecting gene gene gene environment interactions application nicotine dependence j hum genet
28,Lung_Cancer,estimate individual trial corresponds middle squares horizontal line gives ci linethe numbers events fraction total number randomized shown treatment groups subgroupthe sum statistics along summary represented middle solid diamonds test heterogeneity trials within subgroup given summary statistics four studies compared year disease free survival rate ci p finding significant heterogeneity among studies x p fig four studies compared year disease free survival rate ci p finding significant heterogeneity x p patients underwent vats underwent open thoracotomy fig heterogeneity sample size sensitivity analyses conducted using larger sample size studies however difference two surgical methods ci heterogeneity p
29,Lung_Cancer,years experience surg endosc cerfoliorj bryantas mccartytp minnichdj prospective study determine incidence non imaged malignant pulmonary nodules patients undergo metastasectomy thoracotomy palpation ann thorac surg discussion downssh blackn feasibility creating checklist assessment methodological quality randomised non randomised studies health care interventions j epidemiol community health kondoh okumurat ohdey nakagawak surgical treatment metastatic malignancies pulmonary metastasis indications outcomes int j clin oncol porterga cantorsb walshgl ruschvw leungdh et al cost effectiveness pulmonary resection systemic chemotherapy management metastatic soft tissue sarcoma combined analysis university texas anderson memorial sloan kettering centers j thorac cardiovasc surg petersenrp phamd burfeindwr hanishsi
30,Lung_Cancer,xenograft models mechanistically nedd localized invasive pseudopods required local matrix degradation depletion nedd impaired invasion cells inactivation membrane bound matrix metalloproteinase mmp excess timp cell surface inactivation mmp accompanied reduced collagenolytic activity soluble metalloproteinases mmp mmp expression nedd sufficient restore activity mmp invasive properties bca cells vitro vivo collectively findings uncover critical steps nedd dependent invasion bca cells implications study provides mechanistic basis potential therapeutic interventions prevent metastasis nedd invasion metastasis breast mmp int j occup environ health int j occup environ health oeh international journal occupational environmental health maney publishing suite c joseph well hanover
31,Lung_Cancer,tumor markers play key role patient management many malignancies potential uses serum tumor markers include aiding early diagnosis determining prognosis prospectively predicting response resistance specific therapies monitoring therapy patients advanced disease kallikrein related peptidases klk member human kallikrein gene family localized chromosome q recent studies reported klk expressed many including prostate ovarian gastric well rectal carcinoma immunofluorometric assay study demonstrated klk expression ovarian tissues marker favorable prognosis since patients klk positive tumors exhibit longer progression free survival pfs overall survival os additionally sasaki et al reported lower klk mrna expression indicator poor prognosis patients however seems
32,Lung_Cancer,log rank test determined pfs os high klk group significantly longer low klk group p p discussion last years numerous studies published attempt refine understanding determinants prognosis analyzing tumor associated markers thought biologic relevance carcinogenic process proteolytic enzymes several catalytic classes emerged important prognostic factors among enzymes many members human tissue kallikrein family secreted serine proteases including klk promising biomarker diagnosis prognosis present study serum klk levels significantly elevated patients compared control subjects making potential adjunctive tools diagnosis furthermore cutoff point ng ml klk sensitivity specificity prediction importantly serum klk levels differ significantly age gender histology
33,Lung_Cancer,two kinds localizing procedures marking thoracoscopically directly visible materials marking radio opaque materials examples directly visible materials hook wire methylene blue indocyanine green ethiodized oil lipiodol barium iodine contrast agents used radio opaque markers marking method strong weak points localization hook wire easy perform carries high risk pneumothorax propensity dislodge transport surgical preparation methylene blue indigo carmine tendency diffuse large area time operation done render localization features inadequate use radio opaque marker barium lipiodol requires intraoperative fluoroscopy confirm adequate excision well lead increased radiation exposure use mixture reported make weakness marking materials example problem dye diffusion
34,Lung_Cancer,cm range cm group cm range cm group b discrete compact nodular opacity achieved subjects scattered nodular opacities small faint opacity fig average value radio opacity mlm hu range hu interval injection sacrifice hr range hr group hr range hr group b time injection initial follow fluoroscopy hr range hr hr range hr group hr range hr hr range hr group b respectively scores extent staining radio opacity demonstrates staining extent localization ability mlm methylene blue total groups staining extent mlm significant smaller methylene blue cm vs cm p mlm showed significantly higher staining ability score
35,Lung_Cancer,extent parenchymal change depends time interval acute injury percutaneous injection lipiodol methylene blue reported animal studies however clinical results show adverse effect acute injury human lungs injection material barium potentially complicate pathologic diagnosis target lesion due acute inflammation knowledge study indicated lipiodol methylene blue hinders histopathologic diagnosis target lesions human lungs small amount material injection human lungs might create significant parenchymal change disrupt underlying disease necessary avoid directly injecting materials target lesion human lungs order avoid adverse effect injection materials underlying disease especially ground glass opacity nodule potential benign lesion several limitations study first included small
36,Lung_Cancer,thoracoscopic operations ann thorac surg mcconnell pi feola gp meyers rl methylene blue stained autologous blood needle localization thoracoscopic resection deep pulmonary nodules j pediatr surg hu j zhang c sun l localization small pulmonary nodules videothoracoscopic surgery anz j surg wicky mayor b cuttat jf schnyder p ct guided localizations pulmonary nodules methylene blue injections thoracoscopic resections chest vandoni cuttat jf wicky suter ct guided methylene blue labelling thoracoscopic resection pulmonary nodules eur j cardiothorac surg lenglinger fx schwarz cd artmann w localization pulmonary nodules thoracoscopic surgery value percutaneous staining methylene blue ajr j roentgenol
37,Lung_Cancer,one dna repair genes ataxia telangiectasia mutated atm gene responsible multisystem autoxomal recessive disorder ataxia telangiectasia plays crucial role recognition signaling repair dna damage especially dna double strand breaks dsbs atm protein member phosphoinositide kinase pi kinases activated dsbs caused ionizing radiation reactive oxygen intermediates activated atm phosphorylate various downstream substates function cell cycle arrest apoptosis dna repair p nbs brca chk therefore genetic variants atm gene may lead structure function change protein act important factors indicating individual susceptibility atm g rs resides promoter atm gene increasing studies shown variations dna promoter sequence may potentially alter
38,Lung_Cancer,basic demographic data environmental risk factor adenocarcinoma cases controls variable cases controls p value female mean age income yuan month education never elementary school junior school senior school upwards fuel smoke exposure b cooking oil fume exposure b family history b passive smoking exposure b p student test used compare frequency distribution demographic variables cases controls b peason chi square used compare frequency distribution demographic variables fuel smoke exposure cooking oil fume exposure family history passive smoking cases controls shown mean ages adenocarcinoma cases controls mean similar p cases female non smokers significant difference distribution education
39,Lung_Cancer,chinese women international journal wu williamsah daixd blotw xuzy sunxw et al among women north east china br j zhongl goldbergms gaoyt jinf indoor air pollution arising chinese style cooking among nonsmoking women living shanghai china epidemiology cambridge mass plos one one public library science san francisco usa pone research biology genetics genetic mutation mutation types genetics medicine clinical research design retrospective studies diagnostic medicine pathology clinical pathology test evaluation oncology detection diagnosis screening treatment chemotherapy drug treatment clinical trials treatment neoplasms intrathoracic tumors non small cell oncology agents clinical validation pcr assay detection egfr mutations
40,Lung_Cancer,bronchioalveolarcarcinoma includes subjects information available ldt laboratory developed test md mutation detected mnd mutation detected slcg inconclusive n data shown statistical considerations mutation detected md defined presence either exon deletion l r mutation mutation detected mnd defined absence exon deletions l r mutation sas stat software used data analysis clinical outcome study statistics kaplan meier survival curves used assess pfs treatment method chemotherapy erlotinib among patients enrolled eurtac trial screened ldt well subset patients determined mutation positive egfr pcr test nonparametric log rank test performed assess pfs patients randomized chemotherapy erlotinib hazard ratio chemotherapy vs erlotinib
41,Lung_Cancer,discussion study supports feasibility performing retrospective clinical validation companion diagnostic prospective therapeutic clinical trials egfr pcr test results highly concordant ldt results used select patients eurtac trial consequence pfs borr subset patients egfr mutations detected egfr pcr test comparable full cohort patients enrolled eurtac trial thus validating use egfr pcr test select patients treatment anti egfr tkis erlotinib median pfs survival versus months erlotinib group versus months ldts egfr pcr test respectively borr versus months erlotinib group versus ldts egfr pcr test respectively among discordant specimens egfr pcr test ldts third mutation testing method agreed egfr
42,Lung_Cancer,methods updated case cohort study nested within cohort female textile workers shanghai china compared exposure histories incident cases diagnosed reference subcohort workers free end follow applied cox proportional hazards modelling estimate exposure response trends adjusted age smoking cumulative exposures lagged years separately time windows years since first exposure results observed associations cumulative exposure irrespective lag interval contrast analyses exposure time windows revealed modestly elevated statistically significant relative risks highest three exposure quintiles exposures occurred years since first exposure conclusions findings support protective effect endotoxin suggestive possible promotion increasing time since first exposure endotoxin lipopolysaccharide epidemiology textile
43,Lung_Cancer,questionnaire domain specific scores change significantly study individual questions significant improvement seen rating quality information provided excellent rose p qualitative evaluation participants experiences overwhelmingly positive reciprocal peer peer visits supported quality improvement seen strong driver change method pairing multidisciplinary teams important particular pairing teams different results good bad allowing teams visit sites ensure two way sharing best practice independent quality improvement facilitator role seen crucial ensure visits remained focussed engagement quality improvement plans maintained finally involvement senior managers crucial successful implementation quality improvement plans detailed findings independent evaluation project reported elsewhere aveling et al discussion outcomes
44,Lung_Cancer,p active treatment intervention vs controls intervention n trusts control n trusts non intervention control non participants combined n trusts abbreviations cns clinical nurse specialist mdt multidisciplinary team sclc small cell total patient questionnaire scores multidisciplinary team intervention group baseline pre end study post low score indicates better experience symbol represents mean score trust intervention group maximum possible score questionnaire quality improvement plan themes quality improvement plan theme number plans multidisciplinary team effectiveness diagnostic pathways treatment pathways access clinical nurse specialists clinical trial recruitment patient experience baseline national audit indicators control n intervention n excluded n
45,Lung_Cancer,mbsr week group based training consisting meditation practices bodyscan gentle yoga sitting walking meditation repeatedly bringing attention back current experience participants gradually learn disengage dysfunctional thoughts directly experience emotions bodily sensations present moment mbsr aims provide participants ability step back ruminating past worrying future simply allow experiences unfold recent meta analysis nonrandomized studies randomized controlled trials rct concluded positive evidence use mindfulness based interventions reducing psychological distress patients among rct reduction symptom severity found anxiety depression corresponding moderate pooled controlled effect sizes hedges g hedges g respectively though mindfulness based interventions seem effective authors note across
46,Lung_Cancer,silent lunch tea break taking care sitting meditation ending choiceless awareness exercise taking care examining improve balance life meditation without cd yoga walking meditation reflect training min breathing space rest life bodyscan reflection training sources information short sitting meditation maintaining practice outcome measures primary outcome measure psychological distress primary outcome measure total score hads developed measure psychological distress somatic patient populations consists item anxiety hads item depression hads subscale hads shows good psychometric properties general medical population including oncology patients internal consistency measured cronbach varied test retest reliability good pearson r obtained though cut scores hads
47,Lung_Cancer,use clinical trials eur j psychometric properties responsiveness eortc quality life questionnaire qlq c patients breast ovarian qual life res bf osoba aaronson n zee b sprangers te velde modification eortc qlq c version based content validity reliability testing large samples patients qual life res hjermstad mj fossa sd bjordal k kaasa test retest study european anization research treatment core quality life questionnaire j clin oncol bergner bobbitt ra carter wb gilson bs sickness impact profile development final revision health status measure med care pot van dyck r deeg djh ervaren druk door informele z constructie
48,Lung_Cancer,however production administration tailor made dc vaccines costly labor intensive next step development dc vaccines designed recombinant protein contains mycobacterium tuberculosis heat shock protein mtbhsp fused single chain variable fragment scfv derived human b cells targets mesothelin mesothelin msln validated immunotherapy target highly overexpressed surface common epithelial including ovarian epithelial malignant mesotheliomas ductal pancreatic adenocarcinomas adenocarcinomas expressed relatively low levels mesothelial cells lining pleura pericardium peritoneum healthy individuals several therapeutic agents targeting msln evaluated preclinical clinical studies recombinant immunotoxin ss p fusion protein anti msln scfv moiety originally isolated yeast display human scfv library demonstrated ability
49,Lung_Cancer,splenocytes harvested mice treated scfvmtbhsp fusion protein equimolar mixture mtbhsp plus p scfv saline n per group stimulated neu peptide msln ld peptide results reported difference nonstimulated media alone stimulated cells expressed frequency parent cd cd cells p values determined using one way anova followed dunnett multiple comparison tests b representative flow data presented c vivo cd cell depletion study fvb nj mice injected p anti cd mab isotype matched irrelevant rat igg treated scfvmtbhsp saline described methods cd cell depletion significantly negatively impacted ascites free survival scfvmtbhsp treated br fvb tumor bearing animals compared non
50,Lung_Cancer,scfvmtbhsp fusion protein increases tumor antigen presentation cross presentation dc vitro current study demonstrated splenic cd cells scfvmtbhsp treated tumor bearing mice could produce cytokines upon specific tumor antigen stimulation ex vivo associated antitumor therapeutic efficacy vivo determine whether scfvmtbhsp promotes tumor specific cell responses enhancing antigen presentation cross presentation antigen presenting cells co cultured br fvb tumor cell primed cells dcs pulsed br fvb tumor cells presence scfv mtbhsp mtbhsp pbs scfvmtbhsp tumor cell pulsed dcs induced significantly higher production ifn granzyme b cd cd tumor cell primed cells compared mtbhsp pbs indicating scfvmtbhsp enhances
51,Lung_Cancer,connected scfv c terminal using overlap pcr approach pcr product scfv linker subcloned pqe mtbhsp n terminal mtbhsp dna fragment scfvmtbhsp pcr amplified cloned ppmy promab downstream human igg fc domain separated fc region signal cleavage sequence tobacco etch virus protease tev enzyme scfvmtbhsp msln targeted fusion protein generated hek cells purified using protein g resin pierce fc region protein g eluted protein cleaved fusion protein tev enzyme promab digestion mtbhsp generated using expression system production purification two proteins accomplished promab biotechnologies inc richmond ca purification higg fc tag removal integrity scfv mtbhsp mtbhsp determined sds
52,Lung_Cancer,mesothelin mtb mycobacterium tuberculosis hsp heat shock protein p intraperitoneal intradermal bmdcs bone marrow derived dendritic cells apcs antigen presenting cells pbmcs peripheral blood mononuclear cells pbls peripheral blood leukocytes lps lipopolysaccharide h e haematoxylin eosin pfa paraformaldehyde dab diaminobenzidine mab monoclonal antibody competing interests authors declare competing interests authors contributions jy played role design experiments acquisition analysis interpretation data writing manuscript pr jn yy nha mn gj xt sk hc pu bf tc pl participated performance experiments sk tb involved design experiments rb involved data analysis er involved setting murine ovarian model provided murine ovarian
53,Lung_Cancer,purpose although egf receptor tyrosine kinase inhibitors egfr tki gefitinib shown dramatic effects egfr mutant patients become resistant various mechanisms including gatekeeper egfr mutation met amplification kras mutation thereafter relapsing azd potent selective orally available mek inhibitor study evaluated therapeutic efficacy azd alone bez orally available potent inhibitor phosphatidylinositol kinase pi k mammalian target rapamycin mtor gefitinib resistant non small cell carcinoma nsclc models experimental design nci h egfr mutation nci h met amplification nci h kras pik ca mutation human nsclc cells subcutaneous injected athymic nude mice respectively mice randomly assigned treatment azd bez azd
54,Lung_Cancer,single agent combination treatment protocols well tolerated mice weight loss signs acute delayed toxicity c antitumor activity azd bez mouse xenograft models human tumors nude mice bearing nci h nci h b nci h c tumors administered mg kg azd twice daily mg kg bez daily days tumors resected nude mice day tumor volume measured using calipers indicated days mean sd n p vs control group p vs control group changes body weight mice treated control group azd bez nude mice bearing nci h nci h b nci h c tumors administered mg kg azd twice
55,Lung_Cancer,non small cell j exp clin res plos one one public library science san francisco usa pone research medicine health sciences oncology treatment radiation therapy feasibility proton transmission beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy tumors dosimetric feasibility study sabr using transmission proton beams mou benjamin beltran chris j park sean olivier kenneth r furutani keith department radiation oncology mayo clinic rochester minnesota united states america deutsch eric editor institut gustave roussy france e mail beltran chrismayo edu competing interests authors declared competing interests exist conceived designed experiments bm kmf ssp kro cjb analyzed
56,Lung_Cancer,fraction needed photon plans translates beam time per field seconds pt sabr plans compared seconds photon plan second time estimate based conservative nc sec dose rate however new proton centers may able achieve greater nc sec thereby reducing time factor decreasing treatment time less seconds per field breath hold techniques may better tolerated greater number patients suboptimal function breath hold technique would minimize tumor motion e itv leading smaller overall irradiation volume interplay would significant issue spot scanning proton therapy utilizes bragg peak would require larger planning volume due various uncertainties need taken account would require
57,Lung_Cancer,rates assignment patients observation chemotherapy expected gene expression analysis treatment assignment feasible survival results encouraging require future validation real time performance quantitative situ ercc rrm analysis requires development adjuvant therapy personalized medicine ercc excision repair cross complementing group rrm ribonucleotide reductase introduction publication international adjuvant trial adjuvant chemotherapy containing platinum agent become standard care patients complete surgical resection american joint committee stage ii iii version non small cell nsclc trial included patients stage iii disease demonstrated absolute improvement overall survival os subgroup analysis indicated os benefit increased stage hazards ratio hr death among patients receiving adjuvant
58,Lung_Cancer,successfully determined protein levels patients ten eligible patients achieve assignment treatment versus observation within day time interval surgical resection time interval surgery assignment ranged days days patients patients specimens received day limit passed patients time interval receipt reporting ranged days days median days patients successful assignment within day time interval surgical resection time receipt reporting ranged days days median days reasons reporting results excess days equipment failure inadequate expression values control specimens required equipment recalibration repeat processing specimens overall time receipt specimens reporting ranged day days median days mean days similar reported patients advanced nsclc range
59,Lung_Cancer,background ocular sebaceous carcinoma uncommon aggressive ocular neoplasm potential regional distant metastasis case presentation year old woman found solitary pulmonary lesion years initial treatment sebaceous carcinoma eyelid video assisted wedge resection undetermined pulmonary nodule carried successfully microscopically tumor showed foamy cytoplasm atypical nuclei consistent metastasis eyelid sebaceous carcinoma conclusion first case report resected solitary pulmonary metastasis eyelid sebaceous carcinoma pulmonary resection good option treatment diagnosis metastatic eyelid sebaceous carcinoma sebaceous carcinoma metastasis solitary metastasis background sebaceous carcinoma eyelid relatively rare malignant tumor accounts less eyelid tumors well rare tumor sebaceous carcinoma mimic benign inflammatory malignant processes
60,Lung_Cancer,decrease baseline urinary prostaglandin e metabolite day open label run period used select eligible patients one hundred twenty patients median age years randomized ap e p e overall median ttp months ap e group months p e group objective response rate groups intent treat analysis subgroup analysis patients aged years younger demonstrated statistically significant ttp benefit ap e hazard ratio confidence interval applicable p overall survival advantage minimum year follow median versus months hazard ratio p common adverse events rash diarrhea fatigue nausea toxicity contributed early discontinuations patients aged years treated ap e first randomized placebo
61,Lung_Cancer,tumor tissue nonmalignant tissue peripheral blood samples obtained iii proband mother ii also multiple adenocarcinomas tumor nonmalignant tissue samples available proband father ii sister iii unaffected peripheral blood samples obtained individuals family members considered critical study excluded pedigree chart preserve confidentiality whole exome sequencing performed individuals ii ii iii iii obtaining permission institutional review board okayama university hospital informed consent patients family members performed whole exome sequencing study tumor dna samples ii tumor peripheral blood dna samples iii peripheral blood dna samples two unaffected family members ii iii used analysis candidate germline alterations restricted variants comparing
62,Lung_Cancer,associated squamous differentiation j clin oncol e e paowgirardn new driver mutations non small cell lancet oncol shigematsuhtakahashitnomuram somatic mutations kinase domain adenocarcinomas res stephensphuntercbignellg intragenic erbb kinase mutations tumours nature bargmanncihungmcweinbergra multiple independent activations neu oncogene point mutation altering transmembrane domain p cell bocharovevmineevksvolynskype spatial structure dimeric transmembrane domain growth factor receptor erbb presumably corresponding receptor active state j biol chem fleishmansjschlessingerjben taln putative molecular activation switch transmembrane domain erbb proc natl acad sci u mineevksbocharovevpustovalovayebocharovaovchupinvvarsenievas spatial structure transmembrane domain heterodimer erbb erbb receptor tyrosine kinases j mol biol baselgajswainsm novel anticancer targets revisiting erbb
63,Lung_Cancer,studies mir contains two putative sp binding sites within upstream region upregulated examined mir expression found mir decreased sp knockdown cells increased imr cells overexpressed gfp sp b suggesting sp positively regulates mir expression luciferase activity driven mir promoter increased h cells overexpressing gfp sp c whereas luciferase activity decrease cells treated sp inhibitor mithramycin results suggested sp involved mir transcriptional activation using tfsearch software analyzed mir promoter identified two putative sp binding elements consequently recruitment sp mir promoter examined e f acetyl histone recruited sp binding elements indicating region could recruit tfs e panel b
64,Lung_Cancer,overexpression gfp sp decreased foxo mrna protein levels dose dependent manner c panel whereas knockdown sp expression increased foxo mrna protein levels c panel b results indicate sp negatively regulates foxo expression sp negatively regulates foxo expression regulating mir sp foxo levels clinical tissue samples studied ihc staining using antibodies sp foxo respectively b cell lysates harvested various cell lines western blotting using antibodies foxo sp tubulin internal control c adeno gfp sp viruses infected imr cells h foxo mrna protein studied rt pcr western blotting respectively gapdh served internal control panel scramble sp shrnas transfected
65,Lung_Cancer,study identified novel pathway sp mediated activation wherein mir expression downregulated expression foxo known mir target gene sp activated mir foxo transcriptional level however foxo protein expression decreased results suggest post transcriptional regulation mirnas powerful mechanism control final level protein expression many coding genes sp binding element promoters harbor conserved mirna target sequences utr knowledge first study demonstrate sp regulates expression target gene regulating promoter activity post transcriptional processing parallel studies characterized regulation mirna sp herein using bioinformatics approach identified several mirnas potentially regulated sp including mir showed sp specifically targets mir promoter region activates mir
66,Lung_Cancer,transfection cells expression vectors done using lipofectamine invitrogen according manufacturer directions reverse transcription polymerase chain reaction rt pcr stem loop rt pcr total rna isolated using trizol reagent invitrogen g rna reverse transcribed using superscript iii enzyme invitrogen pcr performed cdna gene specific primers sp f tgc agc aga att gag tca cc r cac aac ata ctg ccc acc ag foxo f gca agc aca gag ttg gat ga r cag gtc gtc cat gag gtt tt gapdh f gag tca acg gat ttg gtc gt r ttg att ttg gag gga tct cg u
67,Lung_Cancer,immunoreactivity detected vectastain abc kit vector laboratories burlingame ca quantitative pcr quantitative real time pcr performed using sybr premix ex taq takara bio otsu shiga japan cfx tm real time system c tm thermal cycler bio rad hercules ca primers quantitative pcr follows firefly luciferase f tca aag agg cga act gtg tg r ggt gtt gga gca aga tgg immunofluorescent staining mirzip mirzip stable expression h cells seeded onto coverslips thickness mm incubated h fixation paraformaldehyde sigma aldrich pbs min permeabilization triton x min cells coverslip blocked bovine serum albumin sigma aldrich h stained antibody
68,Lung_Cancer,background gene based estimate risk smokers shown act smoking cessation motivator hospital recruited subjects objective trial determine motivator effective subjects recruited nhs primary care unit method design subjects recruited mailings using smoking entries gp electronic data base total practice population identify smokers may want quit smoking cessation clinics based medical centre premises run eight weeks clinics randomised gene based test estimation risk act controls groups primary endpoint smoking cessation eight weeks six months secondary outcomes include ranking gene based test smoking cessation motivators discussion results inform whether gene based test effective motivator acceptable subjects recruited primary
69,Lung_Cancer,designed determine subjects quit smoking cut subjects failed quit still plan section asks general motivators components smoking cessation programme subjects asked score motivators smoking cessation aids efficacy helping quit questions section almost identical validated questionnaire also questions whether subject would recommend respiragene test relative friend open ended question subjects add comments concept test predicts susceptibility smoker data quality assurance study designed reported accordance consort consolidated statement reporting trials data controlled accordance data protection legislation institutional protocols sussex nhs research consortium nhs policies research information governance ensuring patient confidentiality data analysed spss statistical package social sciences version
70,Lung_Cancer,biochemistry biomarkers medicine health sciences diagnostic medicine gastroenterology hepatology gastrointestinal oncology basic research metastasis neoplasms carcinomas adenocarcinomas colon adenocarcinoma gastrointestinal tumors pathology laboratory medicine anatomical pathology surgical pathology molecular pathology clinical implication associated microvasculature fibroblast advanced colorectal patients synchronous metachronous metastases associated microenvironment advanced colorectal kwak yoonjin lee hee eun kim woo ho kim duck woo kang sung bum lee hye seung department pathology seoul national university hospital seoul south korea department pathology seoul national university college medicine seoul south korea department surgery seoul national university bundang hospital seongnam si gyeonggi south korea department pathology seoul
71,Lung_Cancer,materials methods patient selection total advanced crc patients synchronous metachronous metastases treated seoul national university bundang hospital seongnam si south korea enrolled study synchronous metastases defined distant metastases occurring within six months primary diagnosis crc metachronous metastases occurring time point tissue used study received patients surgical resection primary tumor related metastases none patients received chemo radiotherapy resection primary tumor medical charts pathology reports reviewed record clinical pathological data glass slides reviewed determine histological type according classification follow information including patient outcome time interval date surgical resection death collected cases lost follow deaths causes crc considered censored
72,Lung_Cancer,g heterogeneity lymphatic vessel density lvd microvessel density mvd amount associated fibroblasts cafs respect tumor location lvd mvd b caf area c significantly different according tumor location g lvd mvd caf area different distant metastasis sites characteristics associated stroma differed respect metastatic site lvd mvd b greater metastatic tumor samples collected samples collected metastatic sites p however amount cafs significant different metastatic sites c despite heterogeneity stromal characteristics crc cases higher lvd mvd cafs center primary tendency higher lvd mvd cafs periphery p table however lvd center periphery primary correlated lvd related distant metastasis table addition
73,Lung_Cancer,amount microvasculature measured lvd mvd also heterogeneous relation metastatic examined cox regression analysis center lvd mvd periphery lvd cafs distant metastasis independently associated patients prognosis addition synchronous distant metastasis age perineural invasion heterogeneity microenvironment cells suggested contribute tumor heterogeneity biologic complexity thus considered managing crc patients addition results showed pten expression altered cafs crcs suggesting cafs might altered gene expression play active role progression supporting information figure prognostic association stromal characteristics relates tumor location analysis performed using cut values obtained maximal chi squared methods tif click additional data file figure representative pten antibody stainings stromal cells
74,Lung_Cancer,significant correlation high microvessel densities better survival histopathology ostmana augstenm associated fibroblasts tumor growth bystanders turning key players curr opin genet dev j natl inst j natl inst jnci jnci jnci journal national institute oxford university press us jnci dju response response gu fangyi wacholder sholom freedman neal panagiotou orestis reyes guzman carolyn bertazzi pier alberto caporaso neil e affiliation authors division epidemiology genetics national institute national institutes health bethesda md universita degli studi di milano milan italy pab correspondence neil e caporaso md division epidemiology genetics national institute room e medical center drive bethesda md
75,Lung_Cancer,week metrics albeit higher c index point estimate meaningfully better week metrics none metrics particularly well breast conclusion alternative cut points recist standards provided meaningful improvement os prediction metrics assessed weeks good predictive performance j thorac oncol j thorac oncol jto journal thoracic oncology lippincott williams wilkins jto original translational oncology comparison immunohistochemical assays fish detecting alk translocation diagnostic histological cytological tumor material le quesne john cantab phd mbbs frcpath maurya manisha phd yancheva slaveya g frcpath brien mary md popat sanjay frcp phd wotherspoon andrew c mbbch frcpath de castro david gonzalez phd frcpath nicholson
76,Lung_Cancer,ventana assay using f antibody gave intense cytoplasmic signal accompanied higher background staining especially noticeable macrophages alk antibody assays produced weaker staining less background two marginally background staining especially macrophages value intensity proportion scores assessed cutoffs positivity set using roc analysis optimize correct classification alk status using fish results standard intensity score alone seen outperform proportion aggregate score therefore intensity scoring using optimized cutoff used subsequent analyses table optimised cutoff values immunohistochemical tests concordance fish ihc shown cases negative fish results positive ihc identified specificity ihc data sensitivity three assays excision specimens small biopsies cytological specimens
77,Lung_Cancer,one limitation study small number cases study although fish positive cases comparable studies relatively small number fish negative cases may affected ability identify fish negative ihc positive cases however study design permit assessment sensitivity ihc assay important consideration possible screening test comparison immunohistochemical assays directly equivalent f assay included proprietary tyramide signal amplification step whereas alk assays conducted using routine diagnostic detection system however study design also several strengths particular use archival diagnostic paraffin blocks fish testing conducted course routine diagnosis make results study directly relevant clinical practice summary find ihc highly sensitive specific test alk
78,Lung_Cancer,male caucasian eastern cooperative oncology group performance status ecog ps median four cycles ziv aflibercept administered common treatment emergent adverse events teaes grade nausea fatigue hypertension common grade teae evaluable patients orr median pfs months conclusion cases rpls observed studies ziv aflibercept clinical development programme rate observed study higher previously observed might related declining renal function hypertension although orr pfs accordance historical first line nsclc studies combination ziv aflibercept cisplatin pemetrexed explored nsclc ziv aflibercept non small cell reversible posterior leukoencephalopathy syndrome anti angiogenesis growth dependent upon angiogenesis maintain source nutrition oxygen folkman vascular endothelial growth
79,Lung_Cancer,protocol approved institutional review boards participating institution informed consent obtained patient study design single arm open label multicentre phase ii study clinicaltrials gov identifier nct patients received three drug combination intravenously day every days ziv aflibercept mg kg first followed pemetrexed mg cisplatin mg premedications consisted folic acid vitamin b dexamethasone prophylactic measure reduce pemetrexed related toxicities standard anti emetics patients could receive six cycles combination therapy patients completed combined chemotherapy maintenance ziv aflibercept every days continue disease progression intolerable toxicity withdrawal study end points assessments two co primary end points objective response rate orr pfs
80,Lung_Cancer,hypertension renal insufficiency two risk factors rpls twenty four patients experienced hypertension grade grade study history hypertension taken antihypertensive medications entering study eight patients hypertension also experienced proteinuria fourteen patients experienced proteinuria grades except single grade none history renal disease fourteen patients experienced crcl decreases treatment six patients crcl decreases ml min treatment cycle efficacy evaluation study closed prematurely statistical power test primary hypothesis patients enrolled patients discontinued early study due aes consent withdrawal investigator decision post baseline tumour assessment excluded efficacy assessment per predefined statistical analysis plan patients evaluable efficacy median pfs months ci orr
81,Lung_Cancer,however phase study stabilisation median haemoglobin values multiple cycles well low rate grade anaemia observed result provides support hypothesis vegf negative regulator erythropoiesis inhibitors may role management anaemia toxicity profile trial consistent published data cisplatin plus pemetrexed known effects ziv aflibercept exception higher anticipated rate rpls gadgeel hypertension third frequent teae known adverse effect anti vegf therapies however higher response rate observed among patients developed hypertension treatment among post hoc analysis observation consistent data ecog suggested improved outcomes associated bevacizumab patients developing hypertension therapy dahlberg et al although cases rpls observed ziv aflibercept studies rate observed
82,Lung_Cancer,non small cell clin patel jd hensing ta rademaker hart em blum mg milton dt bonomi pd phase ii study pemetrexed carboplatin plus bevacizumab maintenance pemetrexed bevacizumab first line therapy nonsquamous non small cell j clin oncol ramlau r gorbunova v ciuleanu te novello ozguroglu goksel baldotto c bennouna j shepherd fa le guennec rey miller va thatcher n scagliotti gv aflibercept docetaxel versus docetaxel alone platinum failure patients advanced metastatic non small cell randomized controlled phase iii trial j clin oncol reck von pawel j zatloukal p ramlau r gorbounova v hirsh v leighl n
83,Lung_Cancer,despite previous investigations remains unclear p catenin p ctn isoforms affect emt tumor cells investigated expression p ctn e cadherin vimentin human non small cell nsclc samples immunohistochemistry found p ctn membrane expression positively correlated e cadherin expression p negatively correlated vimentin expression lymph node metastasis p meanwhile p ctn cytoplasmic expression negatively correlated e cadherin expression p positively correlated vimentin expression lymph node metastasis p cells expressing high h spc low h lk levels p ctn screen investigate impact emt e cadherin restricted cell membrane h h cells whereas expressed cytoplasm spc lk cells ablation
84,Lung_Cancer,immunostaining performed streptavidin peroxidase p method tissue sections incubated p ctn mouse monoclonal antibody cat bd transduction laboratories lexington ky usa e cadherin rabbit monoclonal antibody cat sc santa cruz biotechnology santa cruz ca usa vimentin rabbit monoclonal antibody ready use cat rma maixin bio fuzhou china c overnight pbs used negative control biotinylated goat anti mouse serum igg biotinylated goat anti rabbit serum igg ready use cat kit maixin bio used secondary antibody washing sections incubated streptavidin biotin conjugated horseradish peroxidase ultrasensitive maixin bio peroxidase reaction developed diaminobenzidine tetrahydrochloride maixin bio light counterstaining performed hematoxylin
85,Lung_Cancer,b e cadherin membrane positive vimentin negative p ctn membrane positive cells c e cadherin negative vimentin positive p ctn cytoplasmic positive cells correlation e cadherin vimentin lymph node metastasis p ctn p ctn n membrane cytolymph nucleolus x p e cadherin negative positive vimentin negative positive lymph node metastasis yes localization p ctn consistent e cadherin cells examined protein expression levels p ctn e cadherin normal hbe cells nine cell lines western blot found expressed mainly isoforms kda kda p ctn although protein expression levels p ctn related e cadherin localization membrane cytoplasm p ctn
86,Lung_Cancer,series processes maintained normal cell cell adhesion connection inhibited emt increased e cadherin expression decreased n cadherin vimentin snail expression well inhibited cell invasiveness h cells previous studies shown although p ctn isoform could bind e cadherin cytoplasm could form effective adhesion complexes membrane epithelial cells furthermore cytoplasmic e cadherin likely full length e cadherin instead cleaved e cadherin fragments e cad se cad kda e cad ctf kda e cad ctf fragment bind p cytoplasm translocate nucleus bind transcriptional repressor kaiso activate wnt b catenin pathway finally promoting emt tumor cells enhancing cell invasion metastasis
87,Lung_Cancer,obtained specifying c l dimensional vector v sophisticated models splines functions illustrated publications cited require application different bases deriving c nevertheless represented extension nonlinear exposure response relationships extension nonlinear case presents complexities anticipated earlier model extended defining additional exposure response function f x express potentially nonlinear exposure response curve along dimension predictor intuitive generalization f x standard exposure response function however function f x w previously proposed easily represented linear combination basis variables generates models linear parameters thus require ad hoc optimization routines importantly representation based strong assumption independency f x w namely exposure response shape
88,Lung_Cancer,identifiability constraints tensor product structure cross basis defined poses identifiability issues particular vx basis variables r multiplied v basis variables c intercept included f x related matrix cross basis variables w full rank parameters regression model identifiable even common intercept included therefore cross basis always defined without intercept basis functions x also basis functions centered specific exposure value x represent reference risk summaries computed bidimensional shape exposure lag response constrained follow prespecified pattern particular priori assumptions lag structure imposed functional constraints basis space left right constraints extremes supporting interval l particularly meaningful smooth functions left constraint
89,Lung_Cancer,radon exposure interest modeled different combinations bases f x w cross basis sx xt given limited information smoking histories analysis cross basis sz zt priori defined natural cubic b spline one knot median yearly packs exposure response step function single cut lag lag structure lag period years however different cross basis functions applied model spends df controlling confounders different amount modeling effect radon depending chosen cross basis sx xt modeling exposure lag response associations time event data assumes definition extended version continuous time varying predictors namely varying exposure history subject ages contributes different risk sets lag
90,Lung_Cancer,data colorado plateau uranium miners cohort interestingly even though model produced flexible definition figures suggest assumption independency holds shapes exposure response lag response curves different values p xp respectively proportional maximum hr constantly experienced lag result reinforces fact cross basis representation based truly bivariate exposure lag response function f w x may appropriately describe specific independency case defined simpler representation f x w prediction specific exposure histories flexible modeling approach described applied predict overall cumulative risk specific exposure history qh outlined section table iii illustrates predicted hr four different models five alternative exposure scenarios approach previously
91,Lung_Cancer,time varying exposure profiles ns subjects represented series occurrences xt time generated random exposure events intensity range exposure lag response associations defined function fs x ws simpler simulate compared truly bivariate alternative value exposure x lag different scenarios explore alternative choices exposure response function fs x lag response function ws obtained simple mathematical functions involving logarithms exponentials specifically fs x specified linear plateau exponential ws constant decay peak see figure supporting information three scenarios nine possible combinations shown top panels others figure supporting information results simulation study three scenarios exposure lag response associations linear constant plateau
92,Lung_Cancer,overfitting characterizing aic selected models scenarios simple exposure lag response dependencies seriously affect performance result line previous findings however aic selected models also suffer bias undercoverage confidence intervals extent part seems related limited flexibility functions applied simulation study may described smoothing problem rather inherent limitation estimators also noted simulation study evaluates limited set exposure response lag response shapes simulated assumption independency different functions cubic splines complex exposure lag response surfaces assessed future simulation studies also extension dlnms penalized splines characterized higher flexibility explored well exploiting previous research bivariate smoothing techniques related problem inferential procedures conditional posteriori
93,Lung_Cancer,pathway level statistics significance testwe introduce five methods candidates ipas method modification existing pathway analysis techniques enabling us test individual tumor sample pathway aberrance using nref summary provided modification existing pathway analysis methods ipasnote significance obtained null distribution generated normal samples collected normal samples nref one one compared nref yield statistics null distribution statistic single case compared null distribution yield p value average zstandardizing gene expression mean standard deviation datasets often used microarray analysis vector z z z zn denotes expression status pathway zi symbolizes standardized expression value th gene number genes belonging pathway n typical
94,Lung_Cancer,bryant et al overall survivalaverage za beer n overall survivalaverage zb fisher gsea euclidean mahalanobis gse n recurrent free survivalaverage zb fisher gsea euclidean mahalanobis aderived mean sd samples dataset bderived mean sd nref prognostic gene expression signatures stages ii iii colon reported seven papers yielding genes total bandres et al barrier et al eschrich et al kopetz abbruzzese lin et al wang et al genes enriched reactome pathways false discovery rate fdr pathway size assumed pathways valid ground truth identified analyzed colon dataset gse stages ii iii considered average z provided best performer sensitivity pathways
95,Lung_Cancer,subset normal samples served nref amino acid synthesis interconversion transamination b unwind dna validation discovered pathwaythe amino acid synthesis interconversion transamination pathway consists genes involved three major reactions described reactome pathways responsible synthesis three amino acids aspartate asparagine glutamate ii synthesis glucose fasting conditions using carbon atoms four amino acids iii conversion amino acids corresponding alpha keto acids coupled conversion glutamate first step catabolism amino acids function makes sense terms glutamine addiction cells nutrients glucose glutamine specifically required cells metabolites growth production adenosine triphosphate munoz pinedo et al myc p revealed associated addiction upregulating glutamine synthesis
96,Lung_Cancer,colon clin res landi mt gene expression signature cigarette smoking role adenocarcinoma development survival plos one e lee es prediction recurrence free survival postoperative non small cell patients using integrated model clinical information gene expression clin res lin yh multiple gene expression classifiers different array platforms predict poor prognosis colorectal clin res lu tp integrated analyses copy number variations gene expression adenocarcinoma plos one e marisa l gene expression classification colon molecular subtypes characterization validation prognostic value plos med e munoz pinedo c metabolism current perspectives future directions cell death dis e smith jj experimentally derived
97,Lung_Cancer,blood samples stored biobank university navarra processed following standard operating procedures approved ethical scientific committees tumor orr treatment assessed using computerized tomography ct scans every two pemetrexed based chemotherapy cycles categorized according response evaluation criteria solid tumors recist v per institutional protocol toxicities recorded pemetrexed based treatment graded according common terminology criteria adverse events ctcae version ts enhancer region genotyping analysis genomic dna extracted peripheral leucocytes genotypes tser vntr snp determined polymerase chain reaction pcr variable number tandem repeat vntr bp polymorphism g c snp first second repeat analyzed dna fragment amplified using previously described pcr
98,Lung_Cancer,presence r r polymorphism seemed predict higher orr compared rest genotypes trend toward statistical significance p subgroup analysis significantly higher orr pemetrexed wild type egfr patients showing r r genotype compared r r r r r r observed p overall response rate treatment polymorphisms observed global distribution polymorphisms pol response n stabilization progression n p value vntr r r r r r r r r pol vntr subanalysis egfr status group native egfr patients r r r r r r r r global distribution snp absence presence global distribution polymorphisms utr pol utr subanalysis smoking habit
99,Lung_Cancer,however none previous studies described egfr status patients analyzed status impacted orr pemetrexed certain ts polymorphisms terms survival present series median follow months pfs superior patients showing r r genotype trend toward statistical significance expected considering higher orr observed patients tser genotype relatively low statistical power clinical cohort may accounting lack full statistical significance observed regarding os advantage pfs observed patients showing r r genotype translated significantly higher median os patients polymorphism compared rest conversely study hu et al specific genotype significantly correlated superior pfs os aforementioned dramatic differences population characteristics series might possibly explain discordance
100,Lung_Cancer,thymidylate synthase ts gene expression primary patients large scale study japanese population ann oncol annonc mdq bosch barrera j gazta aga ceballos j prez gracia jl lpez picazo jm garc foncillas j ferrer sanz ml pretel idoate gil bazo toxic epidermal necrolysis related pemetrexed carboplatin vitamin b folic acid supplementation advanced non small cell onkologie bosch barrera j montero lpez picazo jm garc foncillas j ferrer yuste jr gil bazo adult onset still disease first cycle pemetrexed gemcitabine non small cell j lungcan michels j spano jp brocheriou deray g khayat izzedine h acute tubular necrosis
101,Lung_Cancer,objective response rate orr patients adenocarcinoma primary endpoint partial responses sided p null hypothesis h orr partial response patients nonadenocarcinoma responders included egfr mutation positive tumors egfr wild type amplification median progression free survival weeks overall n weeks n patients egfr mutation positive tumors common treatment related adverse events grade severity manageable standard supportive care included diarrhea grade g acneiform dermatitis g exfoliative rash g dry skin g fatigue g stomatitis g six patients discontinued due treatment related adverse events patient report nsclc symptoms dyspnea cough pain chest arm shoulder showed improvement first observed weeks therapy
102,Lung_Cancer,disease treatment related symptoms pharmacokinetics pk pre posttreatment concentrations extracellular domains egfr serum genetic variation family kras genes free tumor dna blood trial conducted compliance declaration helsinki international conference harmonization good clinical practice guidelines protocol approved institutional review boards independent ethics committees participating investigational centers patients provided written informed consent prior study participation evaluation antitumor activity evaluation antitumor activity per recist version investigator review tumor assessments performed baseline end every even numbered cycle progressive disease suspected evaluation safety tolerability safety tolerability assessed standard methods initiation study treatment days last dose study drug adverse events aes graded
103,Lung_Cancer,patients n pfs eventsf n pfs weeks ci pfs probability months ci deaths n os weeks survival probability months ci survival probability months ci total patients censored pfs arm arm b arm patients discontinued treatment first study assessment ae global deterioration inadequate baseline assessment still ongoing study treatment longer willing participate pd documented arm b patient discontinued ae sd longer willing participate pd documented using exact method based binomial distribution b arm one sided p value hypothesis testing h orr using exact binomial test arm b one sided p value hypothesis testing h orr using exact
104,Lung_Cancer,introduction leading cause related deaths worldwide whereas non small cell nsclc represents frequent type nsclc accounts approximately cases year overall survival rate less approximately patients diagnosed nsclc unresectable stage iii disease medically inoperable disease radiation therapy regarded main treatment strategy nsclc long time however radioresistance key issue limiting effects radiotherapy possibly due tumor heterogeneity terms cell origin pathology etiology molecular genetic pathogenesis nsclc cells often resistant radiotherapy turn induces local recurrence nsclc therefore development novel approaches treatment nsclc including targeted gene treatment radiosensitizer treat lethal disease urgently needed enhance survival rate patients micrornas mirnas class short
105,Lung_Cancer,non small cell international journal molecular medicine roy yu padhye sb sarkar fh majumdar ap difluorinated curcumin cdf restores pten expression colon cells regulating mir plos one e mir expression knocked transfecting nsclc cells anti mir mir expression cells h transfection anti mir nc anti mir detected taqman real time quantitative rt pcr mean standard deviation expression levels relative u expression levels shown normalized expression cells transfected anti mir nc experiments performed least triplicate p versus cells transfected anti mir nc clonogenic survival nsclc cells varying doses ionizing radiation cells transfected either anti mir anti mir
106,Lung_Cancer,division anatomic molecular pathology division laboratory genomic medicine euclid ave st louis mo eduncavagepath wustl edu american society investigative pathology association molecular pathology published elsevier inc rights reserved american society investigative pathology association molecular pathology document may redistributed reused subject certain conditions identification recurrent gene rearrangements clinical laboratory cornerstone risk stratification treatment decisions many malignant tumors studies reported targeted next generation sequencing assays potential identify rearrangements however utility clinical laboratory unknown examine sensitivity specificity alk kmt mll rearrangement detection next generation sequencing clinical laboratory analyzed series seven alk rearranged six kmt rearranged leukemias alk kmt rearrangement
107,Lung_Cancer,shows frame acquisition patient number surface rendered tumor inclusive volume interest four different respiratory phases shown b tumor well surrounding anatomy exhibit significant deformation phase phase shows motion trajectories extracted two time series one patient mri based monitoring multiple respiratory cycles yields interesting observations case patient number little cycle cycle variation respiratory pattern evidenced motion trajectory diaphragm furthermore motion tumor centroid well correlated motion diaphragm r indicating case diaphragmatic motion appropriate surrogate tumor motion finally motion individual points tumor boundary e pixels comprising edges tumor mass well correlated tumor centroid b r indicating absence significant rotation
108,Lung_Cancer,anchorage tissue cells physical environment obligate requirement survival lost mature hematopoietic transformed epithelial cells find lymphocyte lineage restricted transcription factor aiolos frequently expressed predicts markedly reduced patient survival aiolos decreases expression large set adhesion related genes disrupting cell cell cell matrix interactions aiolos also reconfigures chromatin structure within shc gene causing isoform specific silencing anchorage reporter p shc blocking anoikis vitro vivo tissues single cells p shc expression inversely correlates aiolos together findings suggest aiolos functions epigenetic driver lymphocyte mimicry metastatic epithelial int j clin exp pathol int j clin exp pathol ijcep international journal clinical
109,Lung_Cancer,pharmacological manipulation hsp levels cells may effective means preventing progression tumours found downregulation hsp ibuprofen vitro enhances antitumoural activity cisplatin ibuprofen prominently suppressed expression hsp cells derived adenocarcinoma sensitized cisplatin association increase mitochondrial apoptotic cascade whereas ibuprofen alone induce cell death cisplatin dependent events occurring downstream mitochondrial disruption accelerated treatment ibuprofen increase cisplatin induced apoptosis caused depletion hsp rna interference evidence increased apoptosis ibuprofen mediated effect hsp observations indicate suppression hsp ibuprofen mediates sensitivity cisplatin enhancing apoptosis several stages mitochondrial cascade ibuprofen therefore potential therapeutic agent might allow lowering doses cisplatin limiting many challenge associated toxicity
110,Lung_Cancer,analyzed effects conferred ibuprofen translocation bax mitochondria cisplatin treated cells observed approximately fold increase amount translocated bax b exclude effect ibuprofen unrelated inhibition hsp performed rnai selective knock hsp studied effects activation bax consistent earlier data presented ibuprofen depletion hsp increased activation bax cisplatin treated cells although extent greater hsp rnai ibuprofen c observations confirmed ibuprofen promotes activation bax dependent cisplatin translocation mitochondria cells b mechanism action mediated inhibition hsp ibuprofen facilitates events occurring upstream downstream mitochondrial disruption cisplatin mediated apoptosis previous studies shown hsp inhibit apoptosis acting downstream mitochondria hsp interacts directly apaf prevent formation
111,Lung_Cancer,ibuprofen suppresses expression hsp adenocarcinoma cells upregulation hsp cell lines cell extract separated sds page immunoblotted anti hsp actin antibody upper panel quantity protein estimated densitometric analysis using scion image scion frederick md usa hsp actin ratios shown lower panel b effect ibuprofen expression hsp protein mrna cells top expression hsp hsc proteins cells treated ibuprofen specified concentrations h examined described left panel bottom densitometric analysis protein level arbitrary unit arb u alternation mrna expression ibuprofen treatment analyzed semiquantitative rt pcr top right panel results representative three separate experiments c effect ibuprofen expression hsp protein h
112,Lung_Cancer,purpose aim prospective study evaluate whether f fdg pet ct performed within two weeks starting erlotinib therapy predict tumor response defined recist criteria weeks treatment patients inoperable stage iiia iv non small cell patients patients methods three f fdg pet ct scans acquired patients days days early pet days late pet erlotinib therapy conventional evaluation including least chest ct baseline versus weeks treatment performed according recist criteria change f fdg uptake compared conventional response progression free survival pfs overall survival os results using roc analysis area curve prediction metabolic non progressive disease mnp early pet ci
113,Lung_Cancer,g example progressive patient pet mp conventional imaging progressive patient right upper lobe nsclc associated mdiastinal lymphadenopathy bone metastases patient sum suvmax hypermetabolic lesions lesions mediastinal lymph nodes one hilar lesion pet pet versus pet pet versus pet respectively based suvmax cut value patient classified mp pet accordance recist evaluation ct scan performed days starting erlotinib mp confirmed pet appearance new lesion subcarinal adenopathy increase suvmax g new subcarinal adenopathy pet patient g example mnp patient non progressive patient right upper lobe nsclc associated mediastinal lymphadenopathy liver bone metastases patient sum suvmax hypermetabolic lesions lesions mediastinal
114,Lung_Cancer,dna whole exome sequencing dna wes currently popular technology however yields low sensitivity low purity tumors rna sequencing rna seq covers expressed exome depth proportional expression hypothesized integrating dna wes rna seq would enable superior mutation detection versus dna wes alone developed first kind method called unceqr detects somatic mutations integrating patient matched rna seq dna wes simulation integrated dna rna model outperformed dna wes model validation patient matched whole genome sequencing demonstrated superior performance integrated model dna wes models including published method published mutation profiles genome wide mutational analysis breast cohorts n revealed remarkable tumor
115,Lung_Cancer,alleles always augmented germline genotype unceqr thus preventing somatic mutation detections alleles even unobserved given germline sequencing mutation annotation analysis sequence mutations annotated gene predicted transcript protein alteration using annovar version refseq gene models non silent mutations referred non silent substitution insertion deletion mutations within translated regions splice site mutations mafs compared one sided fisher exact tests mutant versus germline read counts significant results false discovery rate sequence alignments visualized using integrative genomics viewer germline variant analysis patient germline variants relative reference genome detected germline dna wes patient matched germline rna seq using unceqrmeta without population
116,Lung_Cancer,half unceqrmeta mutations rna evidence based dna evidence surprisingly among unceqrmeta expressed somatic mutations rna dna mutant read evidence maf rna often significantly greater dna expressed mutations breast fdr supplementary figure increase often fold expressed mutations breast contrast dna maf significantly greater rna maf much lower frequency expressed mutations breast fdr control germline variants detected germline dna wes patient matched germline rna seq relative reference genome unceqrmeta settings somatic mutation detection b supplementary figure b contrast expressed somatic mutations expressed germline variants displayed rare significant differences allele fraction rna greater dna breast dna rna breast therefore
117,Lung_Cancer,summary addition rna seq dna wes substantially boosted mutation sensitivity low purity tumors example somatic mutation detectable rna dna integration mutation detected unceqrmetap e read alignment display integrative genomics viewer low purity breast tumor major mutational hotspot pik ca increased mutation rates driver therapeutically targeted genes determine unceqrmeta made new mutation discoveries patients tumor genomes unceqrmeta mutations compared previously published patient mutation profiles triplet cohorts specifically tumors non silent mutations change protein sequence contribute development unceqrmeta novel compared published profiles tabulated within genes known relevant development genes gene census published driver genes five hundred sixty seven
118,Lung_Cancer,procedures repeated distance cm creating parallel lesions order analyse tissue lesions thermal damage addition two implanted capsules tissue simulating nodule resected either laser monopolar cutter resection surfaces examined magnetic resonance imaging histology tissue damage finally created cm wide mark surface test resection capacity instruments within min results laser created sharply delineated lesions vaporization coagulation zone without thermal damage surrounding tissue lowering working speed zone extended working speed mm mean vaporization depth using laser mm mean coagulation depth mm working speed monopolar cutter demonstrated greater cutting effect mean vaporization depth mm p without leaving much coagulation resection
119,Lung_Cancer,specific analysis demonstrated pre treatment diameter metastatic lesions moderately positive association percent change post treatment tumor diameter r fewer target lesions three ans association liver lymph node kidney lesion size percent change post treatment tumor diameter percent changes target lesion size differed significantly four individual ans p kruskal wallis test mean sd percent changes target lesion size liver lymph nodes kidney respectively target lesions showed greatest change size significantly greater liver kidney p respectively difference percent change target lesion size lymph nodes p association pre treatment tumor size percent change lesion size sunitinib treatment association pre
120,Lung_Cancer,however results raised several specific questions first tumor histology progression risk may affect response tkis tkis associated good response patients ccrcc less effective non ccrcc similarly patients favorable risk factors greater chance good tumor response poorer risk factors second possibility bias terms types tki selected given sunitinib showed higher response rate sorafenib patients larger rapidly growing tumors may allocated sunitinib rather sorafenib clinical practice third efficacy based initial tumor size may differ different ans although previous study compared mean lesion size reductions different ans compare effect initial tumor size individual ans therefore unclear association initial lesion
121,Lung_Cancer,non small cell nsclcs study searched hla hla restricted epitopes derived eml alk screening predicted eml alk derived candidate peptides induction tumor reactive ctls nine eml alk derived peptides selected computer algorithm based permissive hla hla binding motif one nine peptides induced peptide specific ctls human peripheral blood mononuclear cells able generate peptide specific ctl clone ctl clone specifically recognized peptide pulsed cells h cells expressing hla eml alk treated ifn h prior examination ctl activity inhibited anti hla class monoclonal antibody w consistent class restricted mechanism cytotoxicity results suggest peptide rlsalesrv novel hla restricted ctl
122,Lung_Cancer,point mutations occur tyrosine kinase domain plays important role oncogenesis peptide array selected eml correlation point mutations possible treatment effective tumor cells resistant alk inhibitors study identified new epitope peptide derived eml alk fusion gene successfully induced hla restricted peptide specific ctl clone demonstrated cytotoxicity eml alk positive tumor cells new epitope based vaccine therapy design eml alk positive cells order obtain stronger effect analysis needed acknowledgements thank professor yano providing h cell line possesses eml alk fusion gene professor h mano providing eml alk fusion dna professor n hirano providing artificial apcs study supported part
123,Lung_Cancer,pdgf bb vegf c expression detected primary nsclc tissues lymphatic micro vessel density lmvd counted results cases pdgf bb vegf c overexpression respectively overexpression pdgf bb vegf c p v overexpression pdgf bb low expression vegf c p v overexpression vegf c low expression pdgf bb p v low expression pdgf bb vegf c p v pdgf bb expression positively related vegf c r p lmvd cases p v much higher p v p addition patients p v younger also larger tumor size likely lymph node metastasis worse histological differentiation p v moreover overall survival os
124,Lung_Cancer,overall survival os curves delineated kaplan meier method compared log rank test tests p values less considered significant p values given results two sided tests results pdgf bb vegf c coexpression primary human nsclc primary human nsclc tissues pdgf bb figure b vegf c figure c expression mainly present cytoplasm cells pdgf bb also found cell membrane occasional weak expression pdgf bb vegf c found stroma paracancerous normal tissues among cases pdgf bb vegf c overexpression respectively cohort patients classified groups according expression pdgf bb vegf c patient shown table overexpressions pdgf bb vegf c p
125,Lung_Cancer,background compared fish qrt pcr analyses immunohistochemistry ihc preferred screening test pathology practices alk rearrangement detection sensitivity specificity ventana alk f ihc assay approved eu asian countries alk rearrangement detection however automated ventana ihc platform available pathology labs study evaluated applicability conventional ihc f antibody routine pathological practice proposed detection methods procedures ensure patients alk missed methods fish ihc analyses performed adenocarcinoma cases ventana ihc qrt pcr assay applied evaluate alk fusion status discordant cases fish ihc association alk clinicopathological characteristics statistically analyzed results ihc sensitivity specificity detecting alk eight alk expressed cases alk five alk
126,Lung_Cancer,fish analysis performed cases evaluate alk gene rearrangement status two hundred eighty six cases informative fish analysis cases identified alk e thirty alk cases showed strong alk expression showed weak alk expression therefore cases showed alk expression alk reviewed fish slides discordant cases cases strong cases weak alk expression cases strong weak alk expression identified alk case strong weak alk expression still alk f regarding alk cases identified original fish analysis case case analysis revealed following case dominant fish signal pattern case one copy single green signal without corresponding orange signal addition fused signals according alk
127,Lung_Cancer,enough cells etc study two cores tmas identified alk initial fish analysis due lack cells similarly biopsies numbers cells often limited making accurate fish analysis difficult ihc analysis study almost cells two cores showed alk expression despite fact alk cells revealed fish analysis rate cellular positivity alk tumors demonstrated due technical limitations fish analysis therefore combining ihc fish analyses results alk status accurately evaluated biopsies ihc analysis using cst f antibody demonstrated sensitivity suggesting ihc analysis effective way prescreen patients fish analysis clinical diagnosis process ihc negative cases fish analysis necessary strongly positive ihc cases fish
128,Lung_Cancer,investigate efficacy safety percutaneous microwave ablation methods twenty six rabbits vx tumor randomly divided experimental control group experimental group microwave ablation guided ultrasound ct performed based location tumor enhanced ct scan carried immediately ablation animals two animals group sacrificed immediately week ablation respectively others followed rest lives results ct scan revealed tumor greatly reduced ablated ablation pathological examination immediately ablation also confirmed tumor reduction ablation survival time animals experimental group significantly longer control group conclusions microwave ablation safe effective method treating rabbits showing potential clinical applicability microwave ablation vx tumor hum pathol hum pathol human pathology
129,Lung_Cancer,validation samples primary aim scheme develop flexible scalable eqa scheme designed assess issues related techniques minimum detection limits used standard laboratory practice focusing exclusively analytical sample processing genotyping reporting phases interpretation results relation clinical context enable avoid significant challenges sample heterogeneity real tissue samples artificial materials used composed formalin fixed paraffin embedded ffpe cell line samples eqa materials designed mimic real tissue samples closely possible contained homogenous mixtures mutant vs wild type cell lines range different allelic ratios paraffin blocks cut sections placed eppendorf tube pathology department vu university medical centre amsterdam netherlands dr erik thunnissen
130,Lung_Cancer,designed ascertain proof principle apply measure successful laboratory performance pilot established scheme design methods used acceptable use larger scheme second round one hundred seventeen laboratories countries registered participated second round due customs issues able get samples labs run second quarter ninety one laboratories submitted results within week time frame remaining labs gave reason submit results different set samples used pilot first round sent laboratories emphasis inclusion mutations allelic frequencies would challenge analytical sensitivity commonly used technologies samples b b code number different one assigned first round given samples addition genotype results participating laboratories also required submit
131,Lung_Cancer,used total samples round scheme suggested adequate number cases proficiency testing area pathology thunnissen et al overall results eqa suggest work done laboratories ensure quality egfr mutation testing meets acceptable standard laboratories passed eqa line findings similar eqa schemes deans et al threshold used points comparable majority eqa schemes field van krieken et al weighted marking errors type differently depending implications patient errors resulting diagnosis analytical failures change diagnosis different mutation marked leniently deduction mark compared resulted wrong diagnosis patient false negative false positive results deduction marks given potentially significant clinical consequences patient error propose change
132,Lung_Cancer,human genome variation society hgvs human genome variation society hgvs example considered acceptable report amino acid change redundancy genetic code means different changes nucleotide level result change amino acid level results eqa scheme suggest technical quality egfr mutational analysis could improved evidenced high level diagnostic errors overall standard reporting acceptable findings also underline importance eqa mechanism reveal errors methodology ensure adequate quality molecular testing regular participation eqa seen routine part diagnostic testing process labs helping improve standardise processes established model robust scalable eqa contribute global optimisation improvements overall quality egfr testing patients nsclc thank laboratories participation
133,Lung_Cancer,e nederlof p van noesel c prinsen cf scheidel k van de ven pm de weger r schuuring e ligtenberg egfr kras quality assurance schemes pathology generating normative data molecular predictive marker analysis targeted therapy j clin pathol van krieken jh normanno n blackhall f boone e botti g carneiro f celik ciardiello f cree ia deans zc edsjo groenen pj kamarainen kreipe hh ligtenberg mj marchetti murray opdam fj patterson sd patton pinto c rouleau e schuuring e sterck taron tejpar timens w thunnissen e van de ven pm van krieken jh siebers ag normanno
134,Lung_Cancer,angelique whitehurst phd ut southwestern medical center forest park drive dallas tx phone angelique whitehurstutsouthwestern edu non small cell nsclc notorious paltry responses first line therapeutic regimens contrast acquired chemoresistance little known molecular underpinnings intrinsic resistance chemo na nsclc report intrinsic resistance paclitaxel nsclc occurs cell autonomous level due uncoupling mitotic defects apoptosis identify components permit escape mitotic stress induced death employed genome wide rnai based strategy combines high throughput toxicity screen live cell imaging platform measure mitotic fate strategy revealed prolonging mitotic arrest small molecule inhibitor apc cyclosome could sensitize otherwise paclitaxel resistant nsclc also
135,Lung_Cancer,biomarker validated braf inhibitor resistant nsclc clinical specimens data reveal multifaceted molecular mechanisms nsclcs establish regulate braf oncogene dependence provide insights braf egfr signaling crosstalk uncover mechanism based strategies optimize clinical responses braf oncogene inhibition targeted therapy combination therapy j thorac oncol j thorac oncol journal thoracic oncology official publication international association study jto nihms membrane carbonic anhydrase ix caix expression relapse risk resected stage ii non small cell stewart j md nunez md behrens c md liu ms lin h phd lee j j phd roth j md heymach j md phd swisher md hong
136,Lung_Cancer,japanese families ftsj locus genome gene amplification mrna expression discovered several non small cell nsclc tissue samples ftsj revealed function pre rrna processing however little known three homologs mammals thus study used e coli rrmj starting point construct phylogenetic tree containing several typological species mammals showed ftsj ortholog rrmj based highly conserved ftsj protein sequences within mammals established basic characteristics ftsj gene expression heat shock response different porcine tissues human cells previous studies shown abnormal expression ftsj nsclc investigated functions ftsj cell invasion migration using human adenocarcinoma rhabdomyosarcoma cell lines materials methods phylogenetic analysis e coli
137,Lung_Cancer,human ftsj gctggtgtgtgtttcctttca cagaatctggtgcctctcgt hsp gcacgttcgacgtgtccat gcttgttctggctgatgtcctt actin ccgtcttcccctccatcgtggg cgcagctcattgtagaaggtgtgg gapdh gagaaacctgccaagtatgatg acctggtcctcagtgtagcc pig ftsj acgagttcccaggagaatcaga tgctttggcaacgacctttaa hsp gcacgttcgacgtgtccat gcttgttctggctgatgtcctt actin catcaccatcggcaacga ttcctgatgtccacgtcgc wound healing assay te te hftsj cells grown mm dishes confluence wound produced scraping cell monolayer sterile p pipette tip wound healing process time lapse images obtained every min hours cell migration area calculated healing area wounding area using imagej program http rsbweb nih gov ij index html invasion assay invasion assay performed te te hftsj cells using trans well chambers pore size merck millipore darmstadt germany upper chamber trans well pre coated
138,Lung_Cancer,result may caused direct exposure tissue increased temperature inhalation hot air g ftsj mrna expression vivo vitro heat shock treatments porcine ftsj hsp b mrna expressions piglets raised c c c week human ftsj c hsp mrna expressions cells hour heat shock c c followed hours recovery c porcine hsp human hsp mrna expression used heat shock response control values equal means se n bars different letters represent significant difference p level human ftsj mrna expression increases heat shock cells results showed ftsj mrna overexpressed porcine heat shock therefore human adenocarcinoma epithelial cell line used confirm
139,Lung_Cancer,results indicate importance rrmj methylation u phylogenetic analysis study rrmj homologs clustered following three groups eukaryota ftsj trm p ftsj mrm p ftsj spb p comparison divergent distance rrmj ancestral roots group ftsj mrm p showed closest relation rrmj ftsj mrm p protein group cerevisiae mrm p studied extensively mitochondrial rrna cerevisiae three nucleotides modified including u rrna ribose methylated mrm p proposed mrm p mitochondrial rrmj ortholog cerevisiae according equivalent catalytic positions um cerevisiae mitochondrial rrna um e coli rrna however mammalian ftsj remains uncharacterized thus performed sequence alignment human ftsj rrmj mrm p ftsj
140,Lung_Cancer,human ftsj porcine ftsj protein structure e coli rrmj resolved b gl et al pdb id eiz b protein structure human ftsj resolved wu et al pdb id nyu c protein structure porcine ftsj predicted using swiss model website human ftsj template helices strands shown green yellow respectively sam residues k k e catalytic center shown ball stick representations respectively tif click additional data file figure porcine ftsj mrna expression porcine tissues expression porcine ftsj mrna measured semi quantitative rt pcr porcine actin mrna used loading control b quantification porcine ftsj mrna expression normalized actin mrna
141,Lung_Cancer,work cannot changed way used commercially introduction non small cell exon deletion l r point mutation epidermal growth factor receptor egfr predictors response egfr tyrosine kinase inhibitors however uncertain whether uncommon egfr mutations associated sensitivity egfr tyrosine kinase inhibitors methods post hoc analysis assess prognostic factors performed use patients egfr mutations exon deletion l r g x l q treated gefitinib nej study compared gefitinib carboplatin paclitaxel first line therapy results nej study patients egfr mutations received gefitinib treatment line cox proportional hazards model indicated performance status response chemotherapy response gefitinib mutation types significant prognostic factors
142,Lung_Cancer,versus months p fig b objective response rate significantly lower patients uncommon egfr mutations compared objective response rate common egfr mutations treated gefitinib versus p supplementary table supplemental digital content http links lww com jto contrast similar objective response rates observed patients uncommon egfr mutations common egfr mutations carboplatin paclitaxel group versus p supplementary table supplemental digital content http links lww com jto figure progression free survival curves gefitinib group carboplatin paclitaxel group b according type epidermal growth factor receptor mutation discussion recent studies suggest nsclc patients uncommon egfr mutations less responsive egfr tkis compared patients
143,Lung_Cancer,center functional epigenetics dana farber institute boston usc epigenome center usc norris comprehensive center los angeles ca usa correspondence landimmail nih gov genetic regulation human epigenome fully appreciated describe effects genetic variants dna methylome human based methylation quantitative trait loci meqtl analyses report cis trans meqtls genetic epigenetic interaction surprising magnitude including regulatory hotspot findings replicated breast kidney tissues show distinct patterns cis meqtls mostly localize cpg sites outside genes promoters cpg islands cgis trans meqtls represented promoter cgis meqtl snps enriched ctcf binding sites dnasei hypersensitivity regions histone marks importantly established risk loci european ancestry
144,Lung_Cancer,meqtl snps affecting cpg sites gene body non cgi regions mostly enriched sq risk fig performed analysis category integrating encode saec data chose saec data cell type may involved sq development restricted enrichment analysis regulatory meqtl snps localized ctcf binding regions dnasei hypersensitive sites histone marks h k h k h k least one ld snp r residing regions strong enrichment sq driven snps overlapping ctcf binding sites p based permutations repressive mark h k p based permutations fig e enrichment test significant excluding snps overlapping regulatory regions p based permutations replication meqtls tcga breast kidney
145,Lung_Cancer,lower replication rate adipose meqtls whole blood samples might explained heterogeneity different cell types whole blood liberal p value threshold led identification large number weak cis meqtls compared cis regulation trans eqtl regulation typically considered complex smaller effect sizes difficult replicated even tissue however study trans meqtls highly reproducible tcga breast kidney tissues notably similarity allows mapping meqtls substantially improved power borrowing strength across tissues meqtl snps strongly associated multiple epigenetic marks chromatin regulators play role maintaining genomic integrity anization found meqtl snps strongly enriched dnase hypersensitive sites sequences bound ctcf modified histones snps could affect
146,Lung_Cancer,dye bias equalization used global scaling factor computed ratio average red green fluorescing normalization control probes methods conducted using methylumi package bioconductor version probe dna methylation level summarized value estimated fraction signal intensity obtained methylated beads total signal intensity probes detection p values considered significantly different background noise labeled missing methylation probes excluded meqtl analysis following criteria met x chromosome annotated repetitive genomic regions annotated harbor snps missing rate values snp probes expected similar matched pair normal tumor tissues performed principal component analysis pca using snp probes confirm labeled pairs performed pca using variable methylation probes
147,Lung_Cancer,regression analysis performed test association gene expression methylation levels chrna gene methylation levels pabpc stard slc genes tested association gwas risk snps gene expression using regression analysis additive model adjusting age sex pca scores based genome wide snps testing enrichment cis meqtls gwas tested enrichment nci gwas european ancestry included three main histologic subtypes adenocarcinoma ad squamous cell carcinoma sq small cell carcinoma sc small number subtypes investigated whether identified cis meqtl snps collectively associated risk tested examining whether gwas p values snps deviated uniform distribution e enrichment high linkage disequilibrium ld snps increased variability enrichment
148,Lung_Cancer,study utilized high performance computational capabilities biowulf linux cluster nih bethesda md http biowulf nih gov grateful eagle participants large number eagle collaborators listed http dceg gov eagle genome atlas project genotype methylation data encode project regulatory region data work supported intramural research program nih nci division epidemiology genetics part norris comprehensive center core grant p ca nci trandisciplinary research tricl genetic associations mechanisms oncology game network u ca aw zw wz ah also funded nci nih hsn e ialo zb also funded nih grants r hl p h r hl whittier foundation hastings foundation zb
149,Lung_Cancer,snp determined related regulatory region snp ld related snp r resides chip seq peaks regulatory regions enrichment cis meqtl snps without trans effects cis trans meqtl snps without cis effects trans snps trans cis effects cis trans baseline proportion control set calculated based snps associated meqtls minor allele frequencies local cpg probe density matching meqtl snps fold changes calculated using control set baseline plos one one public library science san francisco usa pone research biology genetics gene expression rna interference genetics molecular cell biology gene expression rna interference medicine oncology neoplasms intrathoracic tumors non small cell
150,Lung_Cancer,pax expression recently found tumors suggesting oncogenic role pax frequently expressed retinoblastoma pancreatic tumors intestinal tumors pax also highly expressed brain breast cell lines pancreatic carcinoma cell lines inhibition pax expression leads decrease cell growth survival pax also regulator met tyrosine kinase receptor expression pancreatic carcinoma cell lines met potential biomarker therapeutic target tumors confirms oncogenic role pax tumorigenesis previously reported pax pax highly expressed non small cell nsclc small cell cell lines respectively little known regarding pax expression function study investigated whether pax regulated cell proliferation nsclc findings show pax promotes g progression activating mapk
151,Lung_Cancer,pax expression obviously weakened pax kd h pax kd cells elucidate whether pax expression effect growth cells rnai used generate pax knock pax kd cell lines selected two target cell lines h showed high levels pax expression showed low levels expression present study pgcsil pax shrna gfp infected h cells cells also infected pgcsil ns shrna gfp pax ns negative control nc determine function pax h h nc nc cells used controls assays pax mrna level h pax kd pax kd cells determined real time pcr confirm whether pax expression specifically inhibited rnai h cells shown
152,Lung_Cancer,patient received two successive courses first line chemotherapy without tumor response tumor cells negative wild type epidermal growth factor receptor k ras variants thus eligible tyrosine kinase inhibitor therapy unfortunately increased levels interleukin carcinoembryonic antigen computed tomography scan results indicated progression crizotinib approved china food drug administration alk gene translocation identified tumor cells fluorescent situ hybridization patient commenced treatment crizotinib remarkably tumor response crizotinib classified partial response days treatment commencement partial response status maintained date weeks conclusion considering remarkable response crizotinib safely conclude patients squamous cell option undergoing alk testing determine indication crizotinib treatment even failed
153,Lung_Cancer,approach discovered nodules different lobes primary tumor nodule fluorescence independent size metabolic activity histology tumor grade vascularity conclusions first human demonstration identifying pulmonary nodules thoracic surgery nir imaging without priori knowledge location existence nir imaging detect pulmonary nodules resections poorly visualized computed tomography difficult discriminate finger palpation mol mol molecular biomed central research downregulation braf activated non coding rna associated poor prognosis non small cell promotes metastasis affecting epithelial mesenchymal transition sun ming sunmingnjmu edu cn liu xiang hua liuxianghuanjmu edu cn wang ke ming qq com nie feng qi qq com kong rong qq com
154,Lung_Cancer,clinical data patients summarized additional file table relative bancr expression nsclc tissues clinical significance relative expression bancr nsclc tissues n compared corresponding non tumor tissues n bancr expression examined qpcr normalized gapdh expression results presented fold change tumor tissues relative normal tissues b bancr expression classified two groups c kaplan meier disease free survival overall survival curves according bancr expression levels p p correlation bancr expression clinicopathological characteristics nsclc patients n characteristics bancr p high cases low cases chi squared test p value age years gender male female histological subtype squamous cell carcinoma adenocarcinoma tnm stage
155,Lung_Cancer,data indicate hdac knockdown induced bancr increase may due inhibition hdac enzymatic activity bancr inhibits nsclc cell viability induces apoptosis assess biological role bancr nsclc investigated effects bancr expression viability apoptosis spca cells qpcr results revealed bancr expression significantly upregulated compared control cells mtt assay results showed growth spc cells transfected pcdna bancr impaired compared control cells b c colony formation assay results revealed clonogenic survival inhibited following overexpression bancr spc cells flow cytometry analysis spc cells showed upregulation bancr expression promoted apoptosis comparison control cells e effects bancr nsclc cell viability apoptosis vitro spc cells
156,Lung_Cancer,malat also known neat nuclear enriched abundant transcript highly conserved nuclear lncrna predictive marker metastasis development study found expression another lncrna bancr significantly downregulated nsclc tissues specifically bancr expression significantly lower later stages tumor development tumors undergone extensive metastasis moreover overall survival time patients lower bancr expression levels significantly shorter patients higher bancr expression levels results indicate bancr expression provided significant independent predictive value tnm stage p demonstrated upregulation bancr expression led significant inhibition cell viability migration invasion promotion apoptosis knockdown bancr expression promoted cell migration invasion bancr induced cell apoptosis may partly via p could
157,Lung_Cancer,methods tissue collection obtained paired nsclc adjacent non tumor tissues patients underwent surgery jiangsu province hospital diagnosed nsclc stages ii iii based histopathological evaluation clinicopathological characteristics including tumor node metastasis tnm staging recorded local systemic treatment conducted patients surgery collected tissue samples immediately snap frozen liquid nitrogen stored c required study approved research ethics committee nanjing medical university china written informed consent obtained patients cell lines five nsclc adenocarcinoma cell lines spc nci h nci h nci h nsclc squamous carcinomas cell line sk mes normal human bronchial epithelial cell line hbe purchased institute biochemistry cell
158,Lung_Cancer,progression free survival pfs compared placebo patients eastern asian locally advanced metastatic non small cell nsclc four chemotherapeutic cycles days per cycle first line platinum based combination chemotherapy without disease progression objective current study evaluate cost effectiveness maintenance gefitinib therapy four chemotherapeutic cycle stand first line platinum based chemotherapy patients locally advanced metastatic nsclc unknown egfr mutations chinese health care system perspective methods findings semi markov model designed evaluate cost effectiveness maintenance gefitinib treatment two parametric weibull log logistic distribution fitted pfs overall survival curves independently one way probabilistic sensitivity analyses conducted assess stability model designed
159,Lung_Cancer,price gefitinib reduced fixed probabilistic sensitivity analysis brand name drug b estimated according local charges china c varied health state utility values pfs ps states presented derived published literature nafees et al assessed quality life using visual analogue scale standard gamble interview participants basis health state descriptions developed rounds depth interviews oncologists oncology specialist nurses psychometric experts according literature diarrhoea rash reported trial significantly associated utility values pfs therefore calculated utility value pfs based published proportion adverse events diarrhoea rash utility values pfs oral therapy pfs plus rash pfs plus diarrhoea utility ps state range used
160,Lung_Cancer,thus mathematical models estimate long term cost effectiveness alternative strategies helpful technique support economic analyses health care resource ulitization current study semi markov model along two parametric weibull log logistic distribution used measuring time dependency transition probabilities calculating direct medical costs lygs qalys gained practice presented trial cost effectiveness evaluation performed analysis economic impact maintenance gefitinib therapy patients locally advanced metastatic nsclc unknown egfr mutations base case analyses year time horizon showed unfavorable icer per qaly gained respectively osa psa revealed model applied robust results monte carlo simulations cases suggested icers maintenance gefitinib therapy higher recommended
161,Lung_Cancer,background american indians alaskan natives ai ans worst year survival racial ethnic groups united states causes disparity unknown authors report examined receipt treatment among ai patients compared white patients methods retrospective cohort study patients diagnosed age years breast colon prostate surveillance epidemiology end results medicare database nationally accepted guidelines surgical adjuvant therapy surveillance selected metrics optimal guideline concordant care treatment analyses compared ai ans matched whites results across types ai ans less likely receive optimal treatment less likely undergo surgery p adjuvant therapy rates significantly lower ai patients breast p colon p rates post treatment surveillance
162,Lung_Cancer,known molecular characteristics cell line shown nsclc cell lines consisted egfr mutant kras mutant mutant nras mutant pik ca mutant eml alk fusion amplified cell lines without gene alterations listed nine egfr wild type cell lines sensitive ad reic hcc resistant subline hcc gr high showed similar degree sensitivity ad reic trend molecular genotype seen sensitive non sensitive cell lines results suggested effect ad reic depend known molecular genotype g sensitivity predictive factors sensitivity ad reic treatment nsclc cell lines inhibition rates nsclc cell lines transfected ad reic compared ad lacz shown black bar moi white
163,Lung_Cancer,categories significantly associated sensitivity ad reic treatment p ad reic sensitivity categories based predictive factors n category category b category c highly sensitive resistant moi jnk grp expression nsclc cell lines treated ad reic western blotting analysis demonstrated significant expression reic dkk protein nsclc cell lines treated ad reic cell lines infected moi ad reic treatment resulted phosphorylation jnk regulation grp b cell lines relatively resistant ad reic activation jnk grp observed higher moi values moi c effect ad reic nsclc tumors xenotransplantation model investigated effect ad reic growth cells vivo one week transplantation tumor volume
164,Lung_Cancer,dla ttn contributed equally manuscript ajw mvg share senior position authorship activated alk ros tyrosine kinases gene fusions found adenocarcinomas highly sensitive selective kinase inhibitors study aimed identifying presence rearrangements human colorectal adenocarcinoma crc specimens using target color break apart fluorescence situ hybridization fish assay simultaneously determine genomic status alk ros among clinical crc specimens analyzed rearrangement positive cases alk ros observed fusion partner alk identified eml fusion partner one ros positive cases slc partner ros positive case remains identified small fraction specimens presented duplicated clustered copies native alk ros addition rearrangements detected samples also harbored
165,Lung_Cancer,methylnaltrexone developed university chicago licensed progenics pharmaceuticals subsequently sub licensed salix pharmaceuticals dr moss paid consultant progenics pharmaceuticals currently paid consultant salix pharmaceuticals receives royalties university chicago patent patent applications relating material pertinent alter authors adherence plos one policies sharing data materials conceived designed experiments fel jm rs pas performed experiments tm bm vap fel analyzed data jm pas contributed reagents materials analysis tools pas jm wrote paper pas e lennon et al open access distributed terms creative commons attribution license permits unrestricted use distribution reproduction medium provided original author source credited recent epidemiologic studies implying
166,Lung_Cancer,rabbit anti mor antibody purchased genetex san antonio tx rabbit anti egfr rabbit anti phosphotyrosine egfr py py py py rabbit anti grb rabbit anti gab rabbit anti phosphotyrosine gab py py rabbit anti src rabbit anti phosphotyrosine src py rabbit anti p pi kinase rabbit anti p pi kinase rabbit anti phosphotyrosine p p pi kinase py py rabbit anti stat rabbit anti phosphotyrosine stat py rabbit anti vimentin rabbit anti zo rabbit anti claudin rabbit anti snail rabbit anti slug antibodies purchased cell signaling technologies danvers mouse anti actin antibody purchased sigma st louis
167,Lung_Cancer,g peripheral mu opioid receptor antagonist methylnaltrexone mntx inhibits egf induced phosphorylation src pi kinase stat human cells panel human h non small cell nsclc cells either untreated control treated nm mntx alone ng ml egf minutes nm mntx ng ml egf minutes cell lysates obtained immunoblotted using anti phospho src py anti phospho p p pi kinase py py bc anti phospho stat py anti actin e antibodies panel b graphical quantitation immunoreactivity experiments performed described b panel normalization total specific protein n independent experiments per condition asterisk indicates statistically significant difference p control error
168,Lung_Cancer,previously reported mor upregulated tissue patients nsclc overexpression mor promotes tumor growth metastasis human nsclc xenograft models data fujioka et al indicate mor regulates egf induced signaling events nsclc considering limited data opioid regulation epithelial mesenchymal transition emt crucial process progression molecular mechanisms integrating cell proliferation migration emt study examined role opioids mor processes present evidence activation growth factor receptors promotes complex formation mu opioid receptor mor grb well src activation events induce recruitment scaffolding protein gab plasma membrane consequent recruitment activation pi kinase akt stat signaling required human proliferation migration emt inhibition mor sirna shrna
169,Lung_Cancer,occurrence plc extremely rare liver carcinoma herein report case patient plc liver transplantation due liver carcinoma plc confirmed clinical manifestations imaging studies cytologic examination exfoliated cells pleural effusion liver carcinoma liver transplantation metastasis pulmonary lymphangitic carcinomatosis background primary liver carcinoma malignancy originating hepatocytes intrahepatic biliary epithelial cells china million carriers hepatitis b virus hbv accounting hbv carriers worldwide high prevalence hbv china underlying reason liver carcinoma malignancy highest morbidity mortality rates china currently resection liver transplantation major strategies treatment liver carcinoma patients hepatic cirrhosis liver transplantation cure liver cirrhosis however liver carcinoma may recur metastasize resection
170,Lung_Cancer,retrospectively reviewed patients stage iii nsclc treated definitive chemoradiation patients underwent pretreatment diagnostic contrast enhanced ct ce ct followed ct treatment simulation used average average ct expiratory ct images ct along ce ct texture extraction histogram gradient co occurrence gray tone difference filtration based techniques used texture feature extraction penalized cox regression implementing cross validation used covariate selection modeling models incorporating texture features image types cpfs compared models incorporating cpfs alone overall survival os local regional control lrc freedom distant metastases ffdm predictive kaplan meier curves generated using leave one cross validation patients stratified based predicted
171,Lung_Cancer,developed coussens werb method hydroxyl radical potent radical produced via fenton reaction classical fenton reaction hydroxyl radical produced mixing ferrous ion solution hydrogen peroxide solution recently developed assay erel reaction used assay ferrous ion solution present reagent mixed hydrogen peroxide present reagent sequentially produced radicals brown colored dianisidinyl radical cation produced hydroxyl radical also potent radicals assay antioxidative effect sample potent free radical reactions initiated produced hydroxyl radical measured assay got excellent precision values lower results expressed mmol trolox equiv l oxidative stress index osi percent ratio tol tac gave osi indicator degree oxidative stress perform
172,Lung_Cancer,one study ferritin level found higher malignant pleural effusion benign pleural effusion experimental study conducted mesothelioma cases found raised copper levels mesothelioma cells reported copper possible marker mesothelioma study copper levels similar asbestos control groups however mm group higher copper level compared two groups ceruloplasmin copper carrying glycoprotein uses iron oxidase activity prevent occurrence toxic iron products present study ceruloplasmin level higher asbestos group control group also higher mm group asbestos group one study investigated acute phase reactants rats asbestos exposure found elevated ceruloplasmin concentrations another study ceruloplasmin levels observed high study finland high serum ceruloplasmin
173,Lung_Cancer,control asbestos mesothelioma p tol mmol h equiv l b cd tac mmol trolox equiv l c f osi c bf crp mg dl af antitrypsin mg dl c cf transferrin g l c cf ferritin ng ml cf copper g ml cf ceruloplasmin mg l cd tol total oxidant level tac total antioxidant capacity osi oxidative stree index crp c reactive protein asignificantly different control p bsignificantly different control p csignificantly different control p dsignificantly different asbestos p esignificantly different asbestos p fsignificantly different asbestos p comput math methods med comput math methods med cmmm
174,Lung_Cancer,differential lysotracker retention may reflect differences basal lysosomal mass lysosomal ph therefore next examined phenothiazine induced changes lysotracker retention lysotracker indicator perturbation lysosomal ph exposure tfp h associated varying degrees loss lysotracker retention almost lc cell lines tested b furthermore highly significant positive correlation extent tfp induced loss lysotracker retention magnitude cytotoxicity b left importantly loss lysotracker retention became irreversible sclc lower tfp concentrations nsclc cells h u c afflicted cells underwent clear mitochondrial depolarization contrast cells exposed non cytotoxic concentrations tfp recovered lysotracker green staining various degrees time c data showed prolonged disruption lysosomal functions
175,Lung_Cancer,therefore envision effects phenothiazines per se well potential chemosensitizing properties help improve outcome relapsed sclc patients longer respond conventional treatment summary present work uncovered novel activity phenothiazines agents capable inhibiting survival inducing cell death human sclc tumor type notoriously difficult treat conventional ct ability rapidly acquire resistance moreover provide evidence showing phenothiazine induced disruption lysosomal functions critically required phenothiazine induced cell death effects sclc especially susceptible inherently low lysosomal number ph finally data suggest analysis intrinsic lysosomal functions may identify sclc cases likely respond phenothiazine based regimens however extended cell line analyses well vivo studies needed
176,Lung_Cancer,study supported grants national basic research program china program cb shao natural science foundation china shao z hou funders role study design data collection analysis decision publish preparation manuscript introduction squamous cell carcinoma scc second common type accounting diagnosed early scc lscc well curable surgical excision however lscc patients encounter high rate recurrence metastasis resistance existing chemotherapeutic agents resection therefore order reduce mortality lscc necessary identify molecular markers early diagnosis elucidate biochemical mechanism governing processes recurrence metastasis well therapeutic resistance proteomic approach using fluorescent dye labeled proteins coupled two dimensional gel electrophoresis dige mass spectrometric ms
177,Lung_Cancer,lscc tissue microarrays contain matched pairs specimens chaoxin biotechnology co shanghai china strict pathological diagnoses post operative follow ups performed patients thirty two cases metastatic lscc patients cases non metastatic lscc patients ihc staining performed detect expression aldoa sections scored positive epithelial cells tumor cells showed staining reaction cytoplasm nucleus quantitative score given estimating percentages positive cells intensity positive staining given scores negative pallide flavens grains buffy grains brown black grains respectively finally total scores samples determined combination quantitative scores time intensity scores score indicated aldoa expression negative positive strongly positive cell culture stable knockdown aldoa
178,Lung_Cancer,national institutes health r dk eur j eur j european journal oxford england j ejca nihms genetic variants lin b gene predict severe radiation pneumonitis patients non small cell treated definitive radiation therapy wen juyi b liu hongliang c wang qiming b liu zhensheng c li yangkai c xiong huihua b xu ting li peng b wang li e b liao zhongxing wei qingyi c adepartment radiation oncology navy general hospital beijing china bdepartment epidemiology university texas anderson center houston tx usa cduke institute duke university medical center durham nc usa ddepartment radiation oncology university texas
179,Lung_Cancer,however data substantial prevalence copd severity asian patients remain limited clinical impact prevalence severity copd among population fully evaluated furthermore patients copd often comorbidities thus whether decision making process therapeutic management patients might independently affected copd remains elusive methods clinical impact prevalence severity copd evaluated japanese patients newly diagnosed sequentially registered underwent bronchoscopy august july nagoya university hospital furthermore explore whether severity airflow obstruction might affect decision propose thoracic surgery curative intent evaluated data patients stage underwent spirometry bronchoscopy results prevalence rate copd among japanese patients underwent bronchoscopy incidence global initiative chronic obstructive disease gold grades
180,Lung_Cancer,although de torres et al demonstrated using well characterized cohort patients copd incidence dense decreased severity airflow obstruction baseline increased severity copd japanese patients newly diagnosed classified mainly gold grade rather gold grade furthermore data showed patients newly classified copd cases compatible incidence severity copd shown previously noted comparing patients undergoing thoracic surgery copd patients average postoperative stay higher greater need prolonged oxygen therapy patients without copd indicating clinical impact coexistence copd prevalence copd might increase japanese patients whereas impact copd related systemic comorbidities also increasingly recognized clinical aspects copd thus whether decision making process involved
181,Lung_Cancer,contributed collection data ni contributed interpretation study data si contributed interpretation radiological data kw contributed development analytic concept data analyses ki contributed interpretation study data ky contributed critical revision manuscript authors read approved final manuscript pre publication history pre publication history paper accessed http www biomedcentral com prepub acknowledgements work partially supported aichi health promotion foundation grant aid thank experienced medical editor nai inc english check revision mathers cd loncar projections global mortality burden disease plos med e mannino dm buist global burden copd risk factors prevalence future trends lancet sekine behnia fujisawa impact copd pulmonary
182,Lung_Cancer,case hcrt one series applied gy gy delivered hemithorax simultaneous integrated boost gy gy delivered r r region planning dose calculation performed eclipse planning system varian medical systems palo alto ca linear accelerator clinac ex trilogy varian medical systems treatment technique dose volume constraints previously published follow recurrence analysis patients followed every three four months clinical examinations ct pet ct scans local tumor progression recurrence defined increasing radiographic abnormality within partially within irradiation field recurrence adjacent field border field defined marginal miss recurrence regional recurrence defined recurrence close proximity within irradiated field tumor recurrence contralateral hemithorax
183,Lung_Cancer,median time distant metastases months hcrt group months dcrt group p hcrt group distant metastases involved contralateral chest three patients abdominal cavity three patients sites affected distant metastases four patients discussion demonstrate retrospective analysis patients mpm treated institution trimodality therapy use postoperative highly conformal radiation techniques hcrt reduces local recurrence comparison dcrt recurrence analysis showed case dcrt patients local recurrence regions clearly underdosed according current radiation protocols doses gy recommended e g sakk contrast patients treated hcrt supports hypothesis hcrt improve local control comparison dcrt improving target volume coverage study patients treated hcrt showed tendency improved
184,Lung_Cancer,suggest three aspects genetically connected cause effect relationships still unknown example physiologic tf binding studies involve many tfs consequently difficult assign nucleosome reanization binding site occupancy particular tf therefore several aspects remain unclear tf binding influence nucleosome anizations locally impact chromatin landscape global level fraction tf binding result reanization nucleosome occupancy tf binding associated changes nucleosome occupancy result altered gene expression mind following characterization two states induction single tf choice determined genomic binding sites tf ii promoter nucleosome occupancy iii transcriptome profiles results demonstrated promoter proximal tf binding influenced expression target gene coupled nucleosome repositioning close
185,Lung_Cancer,actin probed antibody sigma catalog gene expression nucleosome positioning chip seq data submitted gene expression omnibus http www ncbi nlm nih gov geo accession numbers gse gse gse gse results analyzed expression regulatory factors including ones involved metastasis transcriptome profiles clinical cases analyses identified metastasis suppressor nme also known nm h ndpk significantly regulated advanced stages across four independent data sets p student test supplementary figure details analysis including experiments performed us confirmed nme induce anti metastatic changes adenocarcinoma derived cells provided supplementary material supplementary information supplementary figures b next determined nme occupancy nucleosome positions transcriptomes
186,Lung_Cancer,functionally validate point show two promoters nme target site occupied nme positioned nucleosomes cells nme depleted cells available nme binding following nme induction supplementary figure case genes found positioned nucleosomes near nme target sites nme depletion relative control cells together suggests contrast nucleosomal changes following increase nme expression nme target sites remain nucleosome occupied cases depletion nme binding site occupancy transcriptionally active associated nucleosome repositioning found occupancy fifth nme target sites transcription target sites concurrent repositioning nucleosomes nme induced condition interestingly repositioning events resulted altered expression genes contrast found genes nme binding site unique induced condition
187,Lung_Cancer,nucleosome positioning multiple mechanisms toward unifying goal molecular cell hughes l jin rando j struhl k functional evolutionary approach identify determinants nucleosome positioning unifying model establishing genome wide pattern molecular cell nelson j denisenko bomsztyk k protocol fast chromatin immunoprecipitation chip method nat protoc li h ruan j durbin r mapping short dna sequencing reads calling variants using mapping quality scores genome res hartsough steeg p nm nucleoside diphosphate kinase human j bioenerg biomembr ouatas salerno palmieri steeg p basic translational advances metastasis nm j bioenerg biomembr vogelstein b kinzler k w genes pathways control nat
188,Lung_Cancer,adenocarcinoma including cases bronchioloalveolar carcinoma expression mir correlations mir homogenously expressed mainly cytoplasm tumor cells also unspecific nuclear staining scoring based cytoplasmic staining staining stromal cells except weak nuclear staining fibroblasts tested correlations mir angiogenic hypoxia molecular markers found significant correlations mir fgf r p hif r p mmp r p univariate analysis shown clinicopathological variables performance status p histology p tumor differentiation p surgical procedure p pathological stage p tumor status p nodal status p vascular infiltration p significant prognostic indicators dss results univariate analyses mir presented figures whole cohort tendency towards better prognosis tumors
189,Lung_Cancer,another study group set different mirnas could used differentiate hepatocellular carcinomas metastatic tumors liver mirna expression differs tumor types within tumor type different patients primary tumors metastases hence may surprising find mir divergent impact different stages nsclc increasing evidence demonstrate adenocarcinomas scc separate entities dissimilar features may respond differently therapy targeted drugs specific effects certain histological subgroups developed certain mirna signatures differentiate scc non scc may facilitate distinction demonstrating significant prognostic effect mir scc adenocarcinomas underscores diversity histological subgroups previous published paper group explored impact mir cohort found mirna stage tissue specific significant impact survival node
190,Lung_Cancer,ann surg yamashitaji kurusuy fujinon saisyojit ogawam detection circulating tumor cells patients non small cell undergoing lobectomy video assisted thoracic surgery potential hazard intraoperative hematogenous tumor cell dissemination j thorac cardiovasc surg int j clin exp pathol int j clin exp pathol ijcep international journal clinical experimental pathology e century publishing corporation original interleukin signaling prevents apoptosis regulating bcl bax via p pathway human non small cell cells liu zi hui wang ming hui ren hong jiu qu wei sun li mei zhang qing fu qiu xue wang en hua department pathology college basic medical sciences
191,Lung_Cancer,among biomarkers genes used distinguish ac scc practice six genes newly discovered biomarkers distinguishing subtypes furthermore nkx considered molecular target targeted therapy ac genes may novel molecular targets gene ontology analysis found two biological processes epidermis development cell adhesion closely related tumorigenesis subtypes nsclc generally current method could extended complex diseases distinguishing subtypes detecting molecular targets targeted therapy authors work supported national natural science foundation china grant nos funders role study design data collection analysis decision publish preparation manuscript introduction leading cause related deaths world divided two classes world health anization non small cell nsclc small
192,Lung_Cancer,protein encoded dsc calcium dependent glycoprotein desmocollin required cell adhesion desmosome formation protein encoded pkp may involved molecular recruitment stabilization desmosome formation protein encoded clca belongs calcium sensitive chloride conductance protein family may serve adhesion molecule metastatic cells four genes dsc dsg pkp clca associated desmosomes found regulated scc compared ac subtype concretely dsg showed high expression scc low expression ac dsc also upregulated scc exclusively primary tumors dsc potential diagnostic marker squamous cell carcinoma pkp showed times greater level expression sccs acs normal thus may useful histopathological diagnosis clca inferred specifically overexpressed scc found subtype
193,Lung_Cancer,blue nodes represent biomarkers identified work yellow nodes represent six genes related nsclc nsclc normal specimens red nodes represent subtypes e ac scc key gene pairs inferred gene subtype higher logic relationships grouped together gene subtype higher logic relationships logic function two logic functions type xor type intuitive biological interpretations logic functions restricted analysis two logic functions key gene pairs defined gene pairs involved gene subtype higher logic relationships logic function xor obtained key gene pairs total gene pairs related ac scc logic functions xor respectively table result may explained strict parameters chose gene ontology analysis
194,Lung_Cancer,although limited evidence confirm rest genes molecular targets targeted therapy genes provide useful clues targeted therapy gene ontology analysis biomarkers inferred gene subtype lower logic relationships significantly enriched biological processes cell adhesion go epidermis development go identified biological processes nonrandom probability values enrichment scores also significant biological processes important tumorigenesis nsclc discovered biomarkers biological processes cell adhesion epidermis development e dst clca dsg pkp fat dsc pvrl krt gjb bnc account half discovered biomarkers expression genes sufficient necessary conditions presence scc well absence ac indicates genes annotated epidermis development cell adhesion may differently regulated ac scc
195,Lung_Cancer,recurrence rate q used evaluate reliability logic relationships follows represents number recurrance times logic relationship random trials number random trials mapping probe phenotype relationships gene phenotype relationships basis lower higher probe phenotype logic relationships lower higher gene phenotype logic relationships generated follows suppose probes detecting genes form set size set respectively unique probe related phenotype gene relates way moreover coefficient lower logic relationship equal mean uncertainty coefficient lower logic relationship directions unique probe pair related phenotype gene pair related way probe pair moreover coefficient higher logic relationship mean uncertainty coefficient higher logic relationship directions suppose probe
196,Lung_Cancer,henry ford health system detroit mi usa direct dose mapping ddm energy mass transfer mapping emt two essential algorithms accumulating dose different anatomic phases reference phase motion tumor tissue deformation delivery radiation therapy ddm based interpolation dose values one dose grid another thus lacks rigor defining dose multiple dose values mapped one dose voxel reference phase due tissue tumor deformation hand emt counts total energy mass transferred voxel reference phase calculates dose dividing energy mass therefore based fundamentally sound physics principles study implemented two algorithms integrated within eclipse tps compared clinical dosimetric difference two algorithms patients
197,Lung_Cancer,since concordant integrative analysis conducted two data sets necessary investigate whether significant results achieved analysis lai et al lai et al discussed necessary evaluate genome wide concordance integrative analysis conducted based likelihood ratio test obtained p values testing hypothesis complete discordance cd model vs partial concordance discordance pcd model complete concordance cc model vs pcd model respectively result suggested expression profiles data sets overall concordant genome wide level avoid possible selection bias still conducted integrative analysis based general pcd model simplified cc model used still observed similar results shown shown gene sets identified subramanian tamayo et
198,Lung_Cancer,results also included supplementary material comparison fdr curves based three data sets comparison false discovery rate fdr curve based proposed method concordant integrative gene set enrichment analysis fdr curves based gene set analysis gsa individual data sets plot black solid curve represents results based method black dashed curve represents results based gsa boston data black dotted curve represents results based gsa michigan data black dot dashed curve represents results based gsa stanford data gray dotted lines represent three fdr levels regulated regulated b differential expression based analysis results presented among gene sets fdr observed many interesting
199,Lung_Cancer,hispanic black white participants ages enrollment prostate colorectal ovarian plco screening trial bmi baseline bmi age bmi change calculated using self reported recalled height weight relative risks stratified race sex adjusted age education marital status smoking results black white participants died follow mean years clear j shaped associations bmi mortality observed among white men women among black men women bottoms curves flatter increasing risks death greater bmi observed higher bmi levels associations bmi age bmi change also appeared stronger magnitude whites versus blacks racial differences appeared pronounced among women conclusion results suggest bmi may weakly associated
200,Lung_Cancer,associations bmi total mortality appeared stronger increasing hrs beginning lower bmi values whites compared blacks racial difference pronounced women highest compared reference category bmi magnitudes hrs similar white hr ci black hr ci men appeared stronger white hr ci versus black hr ci women adjusting reporting error using nhanes data associations bmi mortality generally became slightly negative exception highest category bmi black men lowest category bmi black women became strongly positive nonetheless shapes bmi curves remained largely similar sensitivity analysis excluded former smokers reduced somewhat excess risk death observed among low bmi otherwise results similar data
